Infectious Disease and Microbiology – Madurella Species

Overview

Madurella species are filamentous fungi that are important causes of eumycetoma, a chronic localized fungal infection involving the skin and subcutaneous tissues. The main species include Madurella grisea and Madurella mycetomatis.

These fungi are found in soil and other environmental material, particularly in tropical and subtropical areas. Infection usually follows traumatic implantation of fungal elements into the skin.

Classification

Genus: Madurella

Species: M. grisea, M. mycetomatis

Type: Filamentous fungus (mold)

Major disease: Eumycetoma

Microbiologic Characteristics

Madurella species are filamentous molds with septate hyphae.

They are environmental fungi commonly associated with:

• Soil

• Plant material

• Organic debris

Within infected tissue, fungal elements may organize into compact structures known as grains or granules, which can sometimes be seen directly in drainage from sinus tracts.

Incubation Period

The incubation period is generally:

Months

Because the infection progresses slowly, symptoms may develop gradually over a prolonged period after traumatic inoculation.

Epidemiology

Madurella fungi are widespread in nature, but symptomatic infection is relatively uncommon.

Most cases occur in:

• Tropical regions

• Subtropical regions

• Northern Africa

• Southern Asia

• Central America

Madurella mycetomatis is an especially important cause of eumycetoma in endemic regions.

Transmission

Infection usually occurs through:

Traumatic implantation of contaminated soil or plant material into the skin

Common exposures include:

• Thorn injuries

• Splinters

• Puncture wounds

• Walking barefoot in endemic areas

The foot is the most commonly affected site.

Clinical Infection

The characteristic infection caused by Madurella species is:

Eumycetoma

This is a chronic, slowly progressive infection that may involve:

• Skin

• Subcutaneous tissue

• Fascia

• Bone in advanced disease

Classic Triad of Mycetoma

The classic clinical triad is:

Subcutaneous swelling

• ●

Draining sinus tracts

• ●

Grains or granules in the discharge

This pattern is highly suggestive of mycetoma.

Madura Foot

When mycetoma involves the foot, it is commonly called:

Madura foot

The affected foot may gradually become enlarged and distorted because of chronic inflammation, fibrosis, sinus tract formation, and progressive extension into deeper tissues.

Clinical Manifestations

Possible findings include:

• Chronic localized swelling

• Subcutaneous nodules

• Multiple sinus tracts

• Purulent drainage

• Visible fungal grains

• Progressive tissue destruction

Common sites include:

• Foot

• Ankle

• Tibial region

Osteomyelitis

Advanced infection may extend into underlying bone and produce:

Osteomyelitis

Bone involvement indicates more extensive disease and can make treatment more difficult.

Pathogenesis

The typical sequence is:

Puncture wound with contaminated soil or vegetation

↓

Fungal implantation into subcutaneous tissue

↓

Chronic granulomatous inflammation

↓

Formation of fungal grains

↓

Draining sinus tracts

↓

Extension into deeper tissues

↓

Possible osteomyelitis

Diagnosis

Diagnosis can be made by:

• Culture of affected tissue

• Histopathologic examination

• Examination of grains in drainage

• Imaging when deep extension is suspected

Fungal Culture

The source emphasizes:

Isolation of the fungus from affected tissue

Culture helps identify the organism and distinguish fungal eumycetoma from bacterial actinomycetoma.

Granules

A particularly important diagnostic clue is the presence of:

Visible grains in purulent discharge

The grains may be large enough to see without microscopy.

Their appearance can help suggest the causative organism.

Histopathology

Biopsy may demonstrate:

• Chronic granulomatous inflammation

• Fungal grains

• Septate fungal hyphae

Histology is especially helpful if culture is negative or tissue involvement is extensive.

Imaging

Imaging can help determine the extent of disease and identify:

• Deep soft-tissue involvement

• Sinus tract extension

• Bone destruction

• Osteomyelitis

MRI may be particularly useful for evaluating advanced disease.

Treatment

The source lists:

Ketoconazole

as treatment.

Ketoconazole is now largely of historical importance because systemic use is limited by toxicity and the availability of safer antifungal agents.

Additional Treatment

The source also lists:

Itraconazole

Itraconazole is commonly used for eumycetoma caused by Madurella species, often for a prolonged period because the infection is chronic.

Surgical Management

Surgical treatment may include:

• Excision of localized lesions

• Debridement of infected tissue

• Removal of necrotic tissue

More extensive surgery may be necessary when there is severe soft-tissue destruction or bone involvement.

Treatment Principle

Management often requires:

Prolonged antifungal therapy

• ●

Surgical excision or debridement when needed

Long-term follow-up is important because recurrence can occur.

Prevention

Prevention focuses on reducing traumatic inoculation.

Useful measures include:

• Wearing protective footwear

• Avoiding walking barefoot in endemic areas

• Avoiding thorn and puncture injuries

• Cleaning penetrating wounds promptly

• Wearing protective gloves when handling vegetation

Eumycetoma vs. Actinomycetoma

Eumycetoma

→ Caused by fungi

→ Madurella is an important cause

→ Usually slowly progressive

→ Treated with antifungal therapy and often surgery

Actinomycetoma

→ Caused by filamentous bacteria

→ Often more inflammatory and aggressive

→ Treated primarily with antibacterial therapy

High-Yield Clinical Pattern

Patient from a tropical or subtropical region

• ●

History of puncture wound or barefoot exposure

• ●

Chronic swelling of the foot

• ●

Multiple draining sinus tracts

• ●

Visible grains in discharge

→ Think Madurella species

→ Eumycetoma / Madura foot

Exam Essentials

Organisms: Madurella grisea, Madurella mycetomatis

Type: Filamentous mold

Major disease: Eumycetoma

Environment: Soil and plant material

Geography: Tropical and subtropical regions

Transmission: Traumatic implantation

Most common site: Foot

Classic triad: Swelling + draining sinus tracts + grains

Major complication: Osteomyelitis

Diagnosis: Culture, histopathology, examination of grains

Source treatment: Ketoconazole

Additional treatment: Itraconazole and surgical removal

Prevention: Avoid puncture wounds and use protective footwear

Key clinical pearl: Madurella species classically cause eumycetoma of the foot after traumatic implantation from soil. The most important pattern is chronic swelling, draining sinus tracts, and visible fungal grains, with osteomyelitis occurring in advanced disease.

Infectious Disease and Microbiology – Human T-Lymphotropic Viruses (HTLV-1 and HTLV-2)

Overview

Human T-lymphotropic viruses HTLV-1 and HTLV-2 are enveloped retroviruses with single-stranded positive-sense RNA genomes. They infect human T lymphocytes and can establish lifelong infection.

HTLV-1 is clearly associated with several important diseases, particularly adult T-cell leukemia/lymphoma (ATLL) and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). By contrast, HTLV-2 has not been firmly linked to a comparable specific malignant disease.

Classification

Viruses: HTLV-1 and HTLV-2

Group: Human T-lymphotropic viruses

Family: Retroviridae

Type: Retroviruses

The historical term “human T-lymphocyte virus” is still commonly used, but “human T-lymphotropic virus” is the standard modern wording.

Microbiologic Characteristics

HTLV-1 and HTLV-2 are:

• Single-stranded positive-sense RNA viruses

• Enveloped

• Retroviruses

• Capable of reverse transcription

• Able to integrate viral DNA into the host-cell genome

Like other retroviruses, they use:

Reverse transcriptase

to convert viral RNA into DNA.

Viral Replication

The general retroviral sequence is:

Viral RNA

↓

Reverse transcription

↓

Proviral DNA

↓

Integration into host genome

↓

Persistent infection of host cells

This ability to integrate into host DNA contributes to lifelong infection.

Incubation and Latency

A precise incubation period is:

Not well defined

For HTLV-1–associated diseases, the interval between infection and clinical disease can be:

Many years to decades

Only a minority of infected individuals develop major HTLV-1–associated complications.

Epidemiology

HTLV infection occurs in multiple regions worldwide.

HTLV-1 is particularly endemic in:

• Southwestern Japan

• The Caribbean

• Parts of sub-Saharan Africa

• Parts of South America

• Other geographically clustered populations

The source specifically highlights high HTLV-1 seropositivity in:

Southeastern Japanese islands and the Caribbean basin

HTLV-2 Epidemiology

HTLV-2 has been detected in several populations and has historically had a strong association with:

Injection drug use

The virus has also been identified in certain indigenous populations.

Transmission

HTLV can be transmitted through infected lymphocytes in:

• Sexual contact

• Blood exposure

• Sharing contaminated injection equipment

• Mother-to-child transmission

Mother-to-child transmission occurs especially through:

Breastfeeding

Prevention Principle

The source states that prevention resembles that used for HIV.

Important preventive measures therefore include:

• Safer-sex practices

• Avoidance of shared needles or injection equipment

• Screening of blood products where applicable

• Prevention of mother-to-child transmission in appropriate settings

HTLV-1 Infection

Major Disease Associations

HTLV-1 is associated with:

Adult T-cell leukemia/lymphoma

and

HTLV-1–associated myelopathy/tropical spastic paraparesis

Other inflammatory and infectious associations can also occur.

Adult T-Cell Leukemia/Lymphoma

Major Malignancy

One of the classic complications of HTLV-1 is:

Adult T-cell leukemia/lymphoma (ATLL)

This is a malignancy of mature T lymphocytes.

Clinical Features

ATLL may present with:

• Lymphadenopathy

• Skin lesions

• Hepatosplenomegaly

• Circulating abnormal T cells

• Immunosuppression

• Opportunistic infections

A particularly important metabolic complication is:

Hypercalcemia

High-Yield ATLL Pattern

Adult from an HTLV-1 endemic region

• ●

T-cell malignancy

• ●

Hypercalcemia

• ●

Characteristic abnormal lymphocytes

→ Think HTLV-1–associated adult T-cell leukemia/lymphoma

Flower Cells

Peripheral blood may show atypical lymphocytes with multilobulated nuclei classically called:

“Flower cells”

This is a memorable hematologic association with ATLL.

HTLV-1–Associated Myelopathy

HAM/TSP

HTLV-1 can cause a chronic progressive neurologic syndrome known as:

HTLV-1–associated myelopathy

or:

Tropical spastic paraparesis

abbreviated:

HAM/TSP

Clinical Manifestations

HAM/TSP typically causes:

• Slowly progressive weakness of both legs

• Spastic paraparesis

• Hyperreflexia

• Gait impairment

• Urinary dysfunction

• Sensory symptoms of variable severity

The condition usually evolves gradually rather than as an acute myelitis.

High-Yield Neurologic Pattern

HTLV-1 exposure

• ●

Slowly progressive bilateral leg weakness

• ●

Spasticity and hyperreflexia

• ●

Bladder dysfunction

→ Think HAM/TSP

Infective Dermatitis

The source lists:

Jamaican infectious dermatitis

This is more commonly referred to as:

HTLV-1–associated infective dermatitis

It is a chronic relapsing dermatitis, particularly recognized in children in HTLV-1 endemic areas.

Strongyloides Association

HTLV-1 infection is also clinically important because it is associated with increased susceptibility to severe or persistent:

Strongyloides stercoralis infection

This interaction can complicate treatment and increase the risk of severe strongyloidiasis.

HTLV-2

Clinical Significance

The source states that:

No disease has been conclusively causally associated with HTLV-2

HTLV-2 was initially isolated from patients with hairy-cell leukemia, but this association was not established as causal.

HTLV-2 Today

HTLV-2 infection is generally considered less pathogenic than HTLV-1.

Some neurologic or inflammatory associations have been reported, but there is no classic disease syndrome equivalent to:

HTLV-1 → ATLL or HAM/TSP

Diagnosis

The source lists:

• Cell culture

• Serology

• Antigen detection

In modern practice, diagnosis is primarily based on:

Serologic testing

with confirmatory testing when required.

Serology

Screening tests detect:

Antibodies against HTLV

Positive screening results may require confirmatory assays to distinguish:

HTLV-1

from:

HTLV-2

Molecular Testing

PCR can detect:

Proviral HTLV DNA

and may help confirm infection or distinguish HTLV-1 from HTLV-2 in selected circumstances.

Treatment

HTLV Infection Itself

The source describes treatment as:

Symptomatic

There is no standard therapy that reliably eradicates integrated HTLV infection from the body.

Management therefore focuses largely on treating:

HTLV-associated diseases

rather than eliminating the latent virus itself.

Adult T-Cell Leukemia/Lymphoma Treatment

Management of ATLL depends on its clinical subtype and severity and may involve:

• Antineoplastic chemotherapy

• Antiviral-based approaches in selected forms

• Targeted therapy

• Hematopoietic stem-cell transplantation in selected patients

This requires specialist hematology/oncology management.

HAM/TSP Treatment

Treatment is generally aimed at:

Reducing inflammation and controlling symptoms

No therapy reliably reverses established neurologic damage in all patients.

Supportive treatment may include:

• Management of spasticity

• Physical rehabilitation

• Bladder management

• Pain management

Prevention

Because HTLV spreads through infected lymphocytes, preventive strategies resemble those used for other blood-borne and sexually transmitted retroviruses.

Important measures include:

• Safer sexual practices

• Avoiding shared injection equipment

• Appropriate blood-donor screening

• Prevention of mother-to-child transmission

Breastfeeding and Transmission

Prolonged breastfeeding is an important route of:

HTLV-1 mother-to-child transmission

In endemic areas, prevention strategies may include modification or avoidance of breastfeeding when appropriate and feasible according to local recommendations.

HTLV-1 vs. HIV

HTLV-1

→ Retrovirus

→ Primarily infects T lymphocytes

→ Promotes T-cell proliferation/transformation

→ Adult T-cell leukemia/lymphoma

→ HAM/TSP

→ Often long latency

HIV

→ Retrovirus

→ Progressive destruction and dysfunction of CD4 T cells

→ Acquired immunodeficiency syndrome

→ Opportunistic infections and malignancies

Thus:

HTLV-1 tends to drive T-cell proliferation

whereas:

HIV primarily causes progressive immune deficiency

HTLV-1 vs. HTLV-2

HTLV-1

→ Strong established disease associations

→ ATLL

→ HAM/TSP

→ Infective dermatitis

→ Endemic clusters in Japan, Caribbean and other regions

HTLV-2

→ Frequently associated epidemiologically with injection drug use

→ No classic strongly established malignant syndrome comparable with HTLV-1

→ Generally lower recognized pathogenicity

High-Yield Clinical Pattern

Patient from an HTLV-1 endemic area

• ●

Adult T-cell malignancy

• ●

Hypercalcemia

→ Think HTLV-1 → Adult T-cell leukemia/lymphoma

Alternative High-Yield Pattern

Chronic progressive spastic weakness of both legs

• ●

Hyperreflexia

• ●

Bladder dysfunction

• ●

HTLV-1 exposure

→ Think HTLV-1–associated myelopathy / tropical spastic paraparesis

Exam Essentials

Viruses: HTLV-1 and HTLV-2

Family: Retroviridae

Genome: Positive-sense single-stranded RNA

Envelope: Present

Key enzyme: Reverse transcriptase

Replication: Proviral DNA integrates into host genome

Transmission: Sexual, blood exposure, shared needles, breastfeeding

HTLV-1 endemic regions: Southwestern Japan, Caribbean, parts of Africa and South America

HTLV-2 association: Injection drug use

Major HTLV-1 malignancy: Adult T-cell leukemia/lymphoma

Classic ATLL metabolic finding: Hypercalcemia

Classic ATLL blood cell: Flower cell

Major neurologic disease: HAM/TSP

Dermatologic association: HTLV-1–associated infective dermatitis

Parasitic association: Increased risk of severe/persistent Strongyloides infection

Diagnosis: Primarily serology, with confirmatory/molecular testing as needed

Treatment: Management of specific HTLV-associated disease; no routine curative antiviral eradication therapy

Prevention: Safer sex, blood/injection precautions, and prevention of mother-to-child transmission

Key clinical pearl: HTLV-1 is the retrovirus classically linked to two major examination syndromes: adult T-cell leukemia/lymphoma—often with hypercalcemia and “flower cells”—and a chronic progressive spastic paraparesis known as HAM/TSP. HTLV-2 is epidemiologically associated with injection drug use but has far weaker established disease associations.

Infectious Disease and Microbiology – Lymphocytic Choriomeningitis Virus

Overview

Lymphocytic choriomeningitis virus (LCMV) is an enveloped RNA virus belonging to the family Arenaviridae. It is a rodent-associated zoonotic virus that usually causes either an asymptomatic or mild febrile illness but can occasionally produce aseptic meningitis, meningoencephalitis, or other neurologic disease.

A characteristic diagnostic clue is marked lymphocytic pleocytosis in the cerebrospinal fluid (CSF).

Classification

Virus: Lymphocytic choriomeningitis virus

Abbreviation: LCMV

Family: Arenaviridae

Genus: Mammarenavirus

Major reservoir: House mouse

LCMV is related to other mammarenaviruses, including Lassa virus, but the clinical syndromes are substantially different.

Microbiologic Characteristics

LCMV is:

• Enveloped

• A single-stranded RNA virus

• Characterized by two RNA genome segments

• Helical in nucleocapsid organization

• An arenavirus

The two genome segments are conventionally called:

L segment

and

S segment

Genome

The source describes the genome as:

Two single-stranded, circular RNA segments

More precisely, arenaviruses possess two single-stranded RNA genome segments with an ambisense coding strategy. The genome is segmented but is not generally described as two conventional circular RNA molecules.

Incubation Period

The incubation period is generally approximately:

1–2 weeks

The exact interval can vary depending on the nature and intensity of exposure.

Epidemiology

Human LCMV infection is:

Uncommon

but the virus has a broad geographic distribution because its principal reservoir, the house mouse, is widespread.

Rodent Reservoir

House Mouse

The classic natural reservoir is:

Mus musculus

the:

Common house mouse

Chronically infected mice may shed virus in:

• Urine

• Feces

• Saliva

• Other secretions

Other Rodent Exposures

Human infection has also been associated with exposure to infected:

• Pet rodents

• Laboratory rodents

• Rodent-contaminated environments

Thus, a history of mouse or other rodent exposure is an important epidemiologic clue.

Transmission

Humans may acquire LCMV through exposure to:

Rodent urine, feces, saliva, or contaminated material

Transmission may occur through:

• Inhalation of contaminated particles

• Direct contact with rodent excreta

• Contaminated food or surfaces

• Contact of contaminated material with damaged skin or mucous membranes

Person-to-Person Transmission

Routine person-to-person transmission is not typical.

Important exceptions include:

Mother-to-fetus transmission

and rare transmission through:

Organ transplantation

These routes are particularly important because they can result in severe disease.

Clinical Infection

Many LCMV infections are:

Asymptomatic

or produce a nonspecific influenza-like illness.

When symptomatic, disease can have a biphasic pattern.

Initial Febrile Illness

The first phase may include:

• Fever

• Malaise

• Myalgia

• Headache

• Nausea or vomiting

• Loss of appetite

The source also lists:

• Adenitis

• Skin rash

These manifestations can occur but are less characteristic than the febrile and neurologic syndromes.

Neurologic Disease

Aseptic Meningitis

LCMV is a classic viral cause of:

Aseptic meningitis

Neurologic manifestations can include:

• Severe headache

• Fever

• Neck stiffness

• Photophobia

• Nausea and vomiting

Meningoencephalitis

More extensive CNS involvement can produce:

Meningoencephalitis

with manifestations such as:

• Altered mental status

• Confusion

• Neurologic abnormalities

• Seizures in severe cases

CSF Findings

Lymphocytic Pleocytosis

A particularly characteristic finding is:

Significant lymphocytic pleocytosis

in the CSF.

This means that CSF contains an increased number of white blood cells with a predominance of:

Lymphocytes

Typical CSF Pattern

LCMV meningitis may demonstrate:

Elevated CSF white blood cells

• ●

Lymphocyte predominance

• ●

Elevated protein

• ●

Glucose that may be reduced

The possibility of low CSF glucose is notable because it can complicate differentiation from bacterial, fungal, or tuberculous meningitis.

High-Yield Meningitis Pattern

Rodent exposure

• ●

Febrile illness

• ●

Aseptic meningitis

• ●

Marked lymphocytic CSF pleocytosis

→ Think LCMV

Congenital LCMV Infection

Important Clinical Association

Maternal infection during pregnancy can result in:

Congenital LCMV infection

The virus can cross the placenta and cause severe fetal CNS and ocular abnormalities.

Congenital Manifestations

Important abnormalities can include:

• Hydrocephalus

• Microcephaly

• Intracranial calcifications

• Chorioretinitis

• Visual impairment

• Neurodevelopmental abnormalities

Congenital infection is an important but often underrecognized manifestation of LCMV.

High-Yield Congenital Pattern

Maternal rodent exposure

• ●

Congenital hydrocephalus

• ●

Chorioretinitis

• ●

Intracranial abnormalities

→ Consider congenital LCMV infection

Transplant-Associated Infection

LCMV has rarely been transmitted through:

Solid-organ transplantation

In immunosuppressed transplant recipients, infection can be severe and potentially fatal.

This is a very different clinical setting from the usually self-limited infection occurring in immunocompetent individuals.

Diagnosis

The source lists:

• Cell culture

• Serology

Serology

Detection of LCMV-specific antibodies can support the diagnosis.

Serologic testing is particularly useful when interpreted together with:

Compatible neurologic disease + rodent exposure

Molecular Diagnosis

Molecular testing using:

RT-PCR

may detect viral RNA in appropriate clinical specimens, particularly in specialized/reference laboratory settings.

Cell Culture

LCMV can be isolated in cell culture, but routine clinical diagnosis generally does not depend on viral culture because specialized laboratory procedures and biosafety precautions are required.

Treatment

The source recommends:

Symptomatic treatment

For most immunocompetent patients:

Supportive care

is the mainstay of management.

Supportive Management

Treatment may include:

• Hydration

• Analgesia

• Antipyretic therapy

• Management of nausea and vomiting

• Neurologic monitoring in meningitis or encephalitis

• Seizure management when necessary

There is no established routine antiviral treatment for uncomplicated LCMV infection.

Prevention

Prevention primarily involves reducing exposure to:

Rodents and rodent excreta

Important measures include:

• Rodent control in homes

• Safe food storage

• Avoiding direct contact with wild mice

• Appropriate cleaning of rodent-contaminated environments

• Careful handling of pet and laboratory rodents

Pregnant individuals should be particularly cautious about exposure to potentially infected rodents because of the risk of congenital infection.

LCMV vs. Lassa Virus

Lymphocytic choriomeningitis virus

→ Arenavirus

→ House mouse reservoir

→ Usually mild febrile illness or aseptic meningitis

→ Marked lymphocytic CSF pleocytosis

→ Congenital CNS/ocular disease possible

→ Treatment primarily supportive

Lassa virus

→ Arenavirus

→ Mastomys multimammate rat reservoir

→ West Africa

→ Lassa hemorrhagic fever

→ Sensorineural hearing loss is an important complication

→ Ribavirin has historically been used in treatment

High-Yield Clinical Pattern

Mouse/rodent exposure

• ●

Biphasic febrile illness

• ●

Meningitis or meningoencephalitis

• ●

Marked lymphocytic pleocytosis in CSF

→ Think Lymphocytic choriomeningitis virus

Exam Essentials

Virus: Lymphocytic choriomeningitis virus (LCMV)

Family: Arenaviridae

Genus: Mammarenavirus

Genome: Two single-stranded RNA segments

Coding strategy: Ambisense

Envelope: Present

Nucleocapsid: Helical

Major reservoir: House mouse (Mus musculus)

Transmission: Exposure to infected rodent excreta/secretions

Frequency: Rare human infection

Major neurologic disease: Aseptic meningitis/meningoencephalitis

Classic CSF finding: Marked lymphocytic pleocytosis

Congenital disease: Hydrocephalus, chorioretinitis and other CNS abnormalities

Diagnosis: Serology, molecular testing such as RT-PCR, specialized viral culture

Treatment: Supportive/symptomatic

Prevention: Rodent control and avoidance of rodent excreta

Key clinical pearl: Think of LCMV when a patient with mouse or rodent exposure develops a febrile illness followed by aseptic meningitis with prominent lymphocytic CSF pleocytosis. Also remember LCMV as an important congenital infection associated particularly with hydrocephalus and chorioretinitis.

Medicine – Friedreich Ataxia

Friedreich ataxia is an inherited progressive neurodegenerative disorder that primarily affects the spinal cord, peripheral nerves, and cerebellar pathways. It is one of the most important hereditary causes of ataxia beginning in childhood or adolescence.

The disorder produces a characteristic combination of progressive gait and limb ataxia, sensory neuropathy, pyramidal tract abnormalities, skeletal deformities, cardiomyopathy, and an increased risk of diabetes mellitus.

1. Inheritance

Friedreich ataxia is inherited in an autosomal recessive pattern.

This means that an affected person usually inherits one abnormal allele from each parent, while the parents are typically unaffected carriers.

Therefore, affected siblings may occur in the same family even when the parents have no neurological symptoms.

2. Genetic Abnormality

Friedreich ataxia is caused by pathogenic variants in the FXN gene on chromosome 9.

The most common abnormality is a GAA trinucleotide-repeat expansion within the FXN gene.

This leads to reduced production of the protein:

Frataxin.

3. Frataxin

Frataxin is a mitochondrial protein involved particularly in iron–sulfur cluster formation and normal mitochondrial energy metabolism.

Reduced frataxin causes mitochondrial dysfunction, abnormal iron handling, oxidative injury, and progressive cellular damage.

Tissues with high metabolic requirements are particularly affected, including:

Nervous system.

Heart.

Pancreatic beta cells.

This helps explain the combination of neurological disease, cardiomyopathy, and diabetes.

4. Age at Onset

Friedreich ataxia usually begins in childhood or adolescence.

An average onset around 10–15 years is often quoted, so the original figure of approximately 12 years is reasonable as a typical teaching value.

However, age at onset is variable, and some patients present later in adulthood.

Earlier onset is often associated with more severe disease.

5. Neurological Pathology

Friedreich ataxia affects several neurological pathways simultaneously.

Important structures include:

Dorsal columns of the spinal cord.

Spinocerebellar tracts.

Corticospinal tracts.

Peripheral sensory nerves and dorsal root ganglia.

This combination explains why patients may have both ataxic features and pyramidal signs, together with peripheral sensory abnormalities.

6. Ataxia

Progressive ataxia is the central neurological feature.

Patients commonly first develop difficulty with:

Walking.

Running.

Balance.

Coordination.

The gait becomes broad-based and unsteady.

As the disorder progresses, the upper limbs may also become ataxic, interfering with writing, eating, and other fine motor tasks.

7. Cerebellar-Type Signs

Patients may demonstrate several signs commonly associated with cerebellar dysfunction.

These can include:

Gait ataxia.

Limb incoordination.

Dysmetria.

Dysarthria.

However, the ataxia in Friedreich disease is not due solely to primary cerebellar degeneration. Loss of proprioceptive information from the dorsal columns and peripheral sensory nerves contributes substantially.

Therefore, it is better regarded as a mixed sensory and spinocerebellar ataxia.

8. Loss of Proprioception

Damage to the dorsal columns and large sensory fibres leads to impaired:

Joint-position sense.

Vibration sensation.

This produces sensory ataxia in addition to the spinocerebellar component.

Patients may therefore become especially unstable when visual input is removed, and a positive Romberg sign can occur.

9. Peripheral Neuropathy

A peripheral sensory neuropathy is common.

Patients may develop:

Reduced vibration sensation.

Reduced proprioception.

Distal sensory impairment.

Absent or reduced tendon reflexes, particularly at the ankles and knees.

This peripheral neuropathy contributes significantly to the gait disturbance.

10. Pyramidal Tract Involvement

The corticospinal tracts may also be affected.

This can produce upper motor neurone features such as:

Extensor plantar responses.

Weakness.

Increased tone or spasticity in some patients.

This creates an important mixed neurological pattern because tendon reflexes may be reduced from peripheral neuropathy while Babinski responses remain extensor because of corticospinal tract disease.

11. Spastic Paraparesis

As the disease advances, weakness and corticospinal tract involvement may result in spastic paraparesis, meaning bilateral weakness of the legs with pyramidal tract involvement.

However, the neurological picture is often mixed rather than a pure spastic paraparesis because peripheral neuropathy and sensory pathway degeneration occur simultaneously.

12. Reflex Pattern

A characteristic examination combination may be:

Absent lower-limb tendon reflexes.

with

Extensor plantar responses.

At first this may seem contradictory.

It occurs because:

Peripheral nerve involvement → reduced tendon reflexes.

while

Corticospinal tract involvement → extensor plantar responses.

This mixed pattern is an important clue to Friedreich ataxia.

13. Pes Cavus

Pes cavus means an abnormally high arch of the foot.

It is common in Friedreich ataxia and develops in association with chronic neuromuscular imbalance.

Other foot deformities may also develop.

Therefore:

Young patient + progressive ataxia + pes cavus → consider Friedreich ataxia.

14. Kyphoscoliosis

Spinal deformity is common.

Patients may develop:

Scoliosis.

Kyphosis.

or

Kyphoscoliosis.

These deformities may become clinically important as the disease progresses and can contribute to impaired posture and respiratory mechanics.

15. High-Arched Palate

A high-arched palate has traditionally been described among the physical features of Friedreich ataxia.

It may form part of the skeletal phenotype but is much less diagnostically important than:

Progressive ataxia.

Pes cavus.

Scoliosis.

Neuropathy.

Cardiomyopathy.

16. Cardiomyopathy

Cardiac involvement is one of the most important non-neurological manifestations of Friedreich ataxia.

Cardiomyopathy is common and may significantly influence prognosis.

The classic cardiac abnormality is hypertrophic cardiomyopathy, although other patterns can occur.

Patients may develop:

Palpitations.

Dyspnoea.

Chest symptoms.

Arrhythmias.

Heart failure in advanced disease.

Regular cardiac assessment is therefore important.

17. Diabetes Mellitus

Friedreich ataxia is associated with abnormalities of glucose metabolism.

Some patients develop:

Impaired glucose tolerance.

or

Diabetes mellitus.

This is related partly to mitochondrial dysfunction involving pancreatic beta cells and insulin metabolism.

Therefore, metabolic monitoring forms part of long-term care.

18. Other Clinical Features

Other manifestations may include:

Dysarthria.

Nystagmus or abnormal eye movements.

Optic neuropathy in some patients.

Hearing impairment in some cases.

Muscle weakness and wasting as disease advances.

The exact phenotype and severity vary considerably between individuals.

19. Diagnosis

Diagnosis is primarily confirmed by genetic testing of the FXN gene, particularly testing for the characteristic GAA repeat expansion.

The clinical picture provides important clues, especially when a young patient has:

Progressive ataxia + sensory neuropathy + absent reflexes + extensor plantar responses + pes cavus/scoliosis + cardiomyopathy.

20. Investigations

Investigations may include:

Genetic testing → confirms FXN-related disease.

ECG and echocardiography → assess cardiac involvement.

Blood glucose or HbA1c → screen for diabetes.

Nerve-conduction studies → demonstrate sensory neuropathy.

MRI → may help exclude alternative neurological disorders and can show spinal cord changes.

21. Treatment

Management is multidisciplinary because Friedreich ataxia affects several organ systems.

Treatment may include:

Physiotherapy and rehabilitation.

Mobility and occupational support.

Management of scoliosis and foot deformities.

Cardiac surveillance and treatment.

Diabetes screening and treatment.

Speech and swallowing assessment when required.

Disease-modifying therapies have also emerged for selected patients in some jurisdictions, but supportive multidisciplinary care remains essential.

22. Friedreich Ataxia – Note Form

Type: hereditary progressive ataxia.

Inheritance: autosomal recessive.

Gene: FXN on chromosome 9.

Common genetic abnormality: GAA trinucleotide-repeat expansion.

Protein affected: frataxin.

Main mechanism: reduced frataxin → mitochondrial dysfunction and progressive neuronal/cardiac injury.

Typical onset: childhood or adolescence, often around the early teenage years.

Ataxia: progressive gait and limb incoordination.

Sensory involvement: loss of vibration and joint-position sense.

Peripheral neuropathy: commonly sensory, causing reduced or absent tendon reflexes.

Pyramidal involvement: extensor plantar responses ± spasticity and weakness.

Skeletal abnormalities: pes cavus, scoliosis/kyphoscoliosis and sometimes high-arched palate.

Cardiac involvement: cardiomyopathy, classically hypertrophic, with possible arrhythmias.

Metabolic association: impaired glucose tolerance and diabetes mellitus.

23. Characteristic Examination Pattern

A particularly useful neurological combination is:

Progressive ataxia.

Loss of proprioception and vibration sensation.

Absent lower-limb reflexes.

Extensor plantar responses.

Pes cavus.

This combination reflects simultaneous damage to:

Peripheral sensory nerves + dorsal columns + spinocerebellar tracts + corticospinal tracts.

Key Clinical Pattern

Think of Friedreich ataxia as:

Autosomal recessive FXN mutation on chromosome 9 → reduced frataxin → mitochondrial dysfunction.

The classic clinical picture is:

Young patient + progressive ataxia + peripheral sensory neuropathy + absent reflexes + extensor plantar responses + pes cavus/kyphoscoliosis + cardiomyopathy ± diabetes.

A particularly high-yield association is:

Friedreich ataxia → neurological disease + skeletal deformity + hypertrophic cardiomyopathy + diabetes mellitus.

Medicine – Visual Field Defects and Lesion Localisation

Visual field defects are important neurological and ophthalmological signs because the pattern of visual loss can help localise a lesion along the visual pathway. A useful first distinction is whether the abnormality affects one eye only or corresponding visual fields of both eyes.

In general:

One-eye defects → think retina or optic nerve.

Both-eye field defects → think optic chiasm or structures behind the chiasm.

1. Visual Pathway

Visual information begins in the retina and travels through the:

Retina → optic nerve → optic chiasm → optic tract → lateral geniculate nucleus → optic radiations → primary visual cortex in the occipital lobe.

At the optic chiasm, fibres arising from the nasal retina cross to the opposite side, whereas fibres from the temporal retina remain uncrossed.

This crossing explains the characteristic visual-field defects produced by lesions at different levels.

2. Lesions Affecting One Eye

Visual loss confined to one eye usually indicates pathology anterior to the optic chiasm.

Possible sites include:

Eye itself.

Retina.

Optic nerve.

The precise visual-field abnormality depends on which structure is affected.

3. Complete Monocular Visual Loss

Complete loss of vision in one eye can occur with severe damage to the ipsilateral optic nerve.

A complete optic nerve transection therefore causes:

Complete blindness of the affected eye.

For example:

Right optic nerve transection → complete right monocular blindness.

The opposite eye remains unaffected if the lesion is confined to the right optic nerve.

4. Other Causes of Severe Monocular Visual Loss

Although optic nerve transection is the classic anatomical example, complete or profound monocular visual loss can also result from severe ocular, retinal, or optic nerve disease.

Important possibilities include:

Central retinal artery occlusion.

Severe optic neuropathy.

Retinal detachment involving the macula.

Major ocular trauma.

Therefore, monocular blindness does not automatically mean that the optic nerve has literally been transected.

5. Central Scotoma

A scotoma is a localized area of reduced or absent vision surrounded by relatively preserved vision.

A central scotoma affects the central part of the visual field and may be experienced as a blurred, dark, or missing area directly in front of the patient.

Central scotomas are particularly associated with diseases affecting the optic nerve or macula.

6. Optic Neuritis

Optic neuritis is an important cause of a central or centrocaecal scotoma.

Typical features include:

Reduced visual acuity.

Central visual-field loss.

Reduced colour vision, particularly red desaturation.

Pain on eye movement.

Relative afferent pupillary defect when unilateral or asymmetric.

Optic neuritis is particularly associated with demyelinating disorders such as multiple sclerosis.

7. Constricted Visual Field

A constricted visual field means that the peripheral visual field progressively narrows while central vision may initially remain relatively preserved.

This may eventually produce tunnel vision.

Important causes include:

Chronic glaucoma.

Chronic papilloedema with secondary optic nerve damage.

Another important cause of progressive peripheral field constriction is retinitis pigmentosa.

8. Chronic Glaucoma

In chronic glaucoma, progressive optic nerve damage produces characteristic visual-field abnormalities.

Early defects may include:

Paracentral scotomas.

Nasal steps.

Arcuate scotomas.

As disease becomes advanced, the remaining visual field may become markedly constricted, producing:

Tunnel vision.

Therefore:

Advanced chronic glaucoma → severe peripheral field constriction.

9. Chronic Papilloedema

Long-standing papilloedema from raised intracranial pressure can eventually damage optic nerve axons.

Early papilloedema often causes an enlarged blind spot, while visual acuity may initially remain relatively preserved.

If papilloedema persists:

Chronic disc swelling → optic nerve damage → secondary optic atrophy → progressive visual-field loss.

Advanced disease can therefore produce substantial field constriction and permanent visual impairment.

10. Lesions Affecting Both Eyes

When a lesion affects corresponding parts of the visual fields of both eyes, pathology at the optic chiasm or behind the chiasm should be considered.

Important sites include:

Optic chiasm.

Optic tract.

Lateral geniculate nucleus.

Optic radiations.

Occipital visual cortex.

The exact field defect helps localise the lesion.

11. Bitemporal Hemianopia

Bitemporal hemianopia means loss of the temporal half of the visual field in both eyes.

This pattern strongly suggests a lesion involving the optic chiasm.

Therefore:

Bitemporal hemianopia → think optic chiasm.

12. Why Chiasmal Lesions Cause Bitemporal Hemianopia

The nasal retinal fibres cross at the optic chiasm.

These nasal retinal fibres carry information from the temporal visual fields.

Compression of the central optic chiasm therefore preferentially damages the crossing nasal fibres.

The result is:

Loss of temporal visual field in both eyes → bitemporal hemianopia.

13. Causes of Chiasmal Lesions

Important causes include:

Pituitary adenoma.

Craniopharyngioma.

Meningioma.

Intracranial aneurysm, depending on its location.

Other suprasellar masses may also compress the optic chiasm.

14. Pituitary Adenoma

A pituitary adenoma is a classic cause of bitemporal hemianopia.

The pituitary gland lies beneath the optic chiasm.

As a pituitary tumour expands upward from the sella turcica, it may compress the inferior aspect of the optic chiasm.

Therefore:

Pituitary mass → optic chiasm compression → bitemporal visual-field loss.

Endocrine abnormalities may coexist depending on whether the tumour secretes hormones or interferes with normal pituitary function.

15. Craniopharyngioma

Craniopharyngiomas are tumours arising in the sellar or suprasellar region.

Because of their proximity to the optic chiasm, they can cause:

Visual-field defects.

Reduced visual acuity.

Endocrine abnormalities.

Symptoms of raised intracranial pressure, particularly with larger lesions.

Bitemporal hemianopia may occur from chiasmal compression.

16. Homonymous Visual-Field Defects

A homonymous visual-field defect affects the same side of the visual field in both eyes.

For example:

Right homonymous hemianopia → loss of the right visual field of both eyes.

This indicates a lesion behind the optic chiasm on the opposite side.

Therefore:

Right homonymous field loss → left retrochiasmal lesion.

Left homonymous field loss → right retrochiasmal lesion.

17. Homonymous Quadrantanopia

A homonymous quadrantanopia means loss of the same quarter of the visual field in both eyes.

This commonly results from a lesion involving part of the optic radiations.

The two important patterns are:

Superior quadrantanopia → temporal lobe lesion.

Inferior quadrantanopia → parietal lobe lesion.

18. Superior Homonymous Quadrantanopia

Fibres carrying information from the superior visual field travel through the inferior optic radiations, which loop anteriorly through the temporal lobe.

This loop is known as Meyer’s loop.

A temporal lobe lesion therefore produces a contralateral superior homonymous quadrantanopia.

A useful memory phrase is:

Temporal lesion → “pie in the sky.”

For example:

Left temporal lobe lesion → right superior homonymous quadrantanopia.

19. Inferior Homonymous Quadrantanopia

Fibres carrying the inferior visual field travel more superiorly through the parietal lobe.

A parietal optic-radiation lesion therefore causes:

Contralateral inferior homonymous quadrantanopia.

A useful memory phrase is:

Parietal lesion → “pie on the floor.”

For example:

Left parietal lesion → right inferior homonymous quadrantanopia.

20. Homonymous Hemianopia

Homonymous hemianopia means loss of the same half of the visual field in both eyes.

It results from a retrochiasmal lesion.

Possible sites include:

Optic tract.

Lateral geniculate nucleus.

Optic radiations.

Occipital cortex.

21. Optic Tract Lesion

An optic tract lesion produces a contralateral homonymous hemianopia.

The defect is often relatively incongruous, meaning that the field defects in the two eyes are not exactly identical in shape or extent.

For example:

Left optic tract lesion → right homonymous hemianopia.

22. Congruity and Lesion Location

As lesions occur farther posteriorly along the visual pathway, homonymous field defects generally become more congruous.

Congruous means that the field defects in the two eyes closely resemble each other.

Therefore, as a general rule:

Anterior retrochiasmal lesion → more incongruous.

Posterior retrochiasmal lesion → more congruous.

This is a useful localisation principle rather than an absolute rule.

23. Lateral Geniculate Lesions

The lateral geniculate nucleus/body is a relay station between the optic tract and optic radiations.

Lesions here can cause a contralateral homonymous visual-field defect, sometimes with characteristic sectoral patterns depending on vascular anatomy.

The original note associates a congruous homonymous hemianopia with a lateral geniculate lesion, but congruity alone does not precisely localise the lesion.

24. Occipital Cortex Lesions

The final part of the visual pathway is the primary visual cortex in the occipital lobe.

An occipital cortex lesion typically causes a highly congruous contralateral homonymous hemianopia.

One particularly important feature is:

Macular sparing.

25. Macular Sparing

Macular sparing means that central vision is preserved despite loss of the surrounding homonymous visual field.

This is classically associated with an occipital cortex lesion, particularly an occipital infarction.

One explanation is that the occipital pole representing central vision may have overlapping vascular supply, although the mechanism is more complex than a simple fixed dual blood supply in every patient.

Therefore:

Homonymous hemianopia + macular sparing → strongly suggests occipital cortex involvement.

26. Visual Field Defects – Note Form

Complete monocular visual loss: severe ipsilateral retinal or optic nerve lesion; complete optic nerve transection is the classic anatomical example.

Central scotoma: optic nerve or macular disease; optic neuritis is an important cause.

Constricted visual field: chronic glaucoma, chronic papilloedema with optic nerve damage, or retinitis pigmentosa.

Bitemporal hemianopia: optic chiasm lesion.

Chiasmal causes: pituitary adenoma, craniopharyngioma, meningioma and other suprasellar masses; some aneurysms may also compress the chiasm.

Superior homonymous quadrantanopia: contralateral temporal lobe/Meyer’s loop lesion.

Inferior homonymous quadrantanopia: contralateral parietal optic-radiation lesion.

Homonymous hemianopia: contralateral lesion behind the optic chiasm.

Incongruous homonymous hemianopia: suggests a relatively anterior retrochiasmal lesion, such as the optic tract.

Increasingly congruous field defects: generally suggest progressively more posterior lesions.

Homonymous hemianopia with macular sparing: classically suggests an occipital cortex lesion.

27. Easy Localisation Sequence

Think of the visual pathway from front to back:

One eye only → retina or optic nerve.

Temporal fields of both eyes lost → optic chiasm.

Same side of visual field lost in both eyes → opposite retrochiasmal pathway.

Superior quadrant lost → opposite temporal lobe.

Inferior quadrant lost → opposite parietal lobe.

Very congruous homonymous hemianopia ± macular sparing → opposite occipital cortex.

Key Clinical Pattern

The most useful rule is:

PRE-CHIASM → ONE EYE.

CHIASM → BITEMPORAL HEMIANOPIA.

POST-CHIASM → CONTRALATERAL HOMONYMOUS FIELD LOSS.

For the optic radiations:

Temporal lobe → superior quadrantanopia → “pie in the sky.”

Parietal lobe → inferior quadrantanopia → “pie on the floor.”

And finally:

Occipital cortex → highly congruous homonymous hemianopia, often with macular sparing.

1. Visual Pathway Visual information begins in the retina and travels through the: Retina → optic nerve → optic chiasm → optic tract → lateral geniculate nucleus → optic radiations → primary visual cortex in the occipital lobe. At the optic chiasm, fibres arising from the nasal retina cross to the opposite side, whereas fibres from the temporal retina remain uncrossed. This crossing explains the characteristic visual-field defects produced by lesions at different levels. 

2. Lesions Affecting One Eye Visual loss confined to one eye usually indicates pathology anterior to the optic chiasm. Possible sites include: Eye itself. Retina. Optic nerve. The precise visual-field abnormality depends on which structure is affected. 

3. Complete Monocular Visual Loss Complete loss of vision in one eye can occur with severe damage to the ipsilateral optic nerve. A complete optic nerve transection therefore causes: Complete blindness of the affected eye. For example: Right optic nerve transection → complete right monocular blindness. The opposite eye remains unaffected if the lesion is confined to the right optic nerve. 

4. Other Causes of Severe Monocular Visual Loss Although optic nerve transection is the classic anatomical example, complete or profound monocular visual loss can also result from severe ocular, retinal, or optic nerve disease. Important possibilities include: Central retinal artery occlusion. Severe optic neuropathy. Retinal detachment involving the macula. Major ocular trauma. Therefore, monocular blindness does not automatically mean that the optic nerve has literally been transected. 

5. Central Scotoma A scotoma is a localized area of reduced or absent vision surrounded by relatively preserved vision. A central scotoma affects the central part of the visual field and may be experienced as a blurred, dark, or missing area directly in front of the patient. Central scotomas are particularly associated with diseases affecting the optic nerve or macula. 

6. Optic Neuritis Optic neuritis is an important cause of a central or centrocaecal scotoma. Typical features include: Reduced visual acuity. Central visual-field loss. Reduced colour vision, particularly red desaturation. Pain on eye movement. Relative afferent pupillary defect when unilateral or asymmetric. Optic neuritis is particularly associated with demyelinating disorders such as multiple sclerosis. 

7. Constricted Visual Field A constricted visual field means that the peripheral visual field progressively narrows while central vision may initially remain relatively preserved. This may eventually produce tunnel vision. Important causes include: Chronic glaucoma. Chronic papilloedema with secondary optic nerve damage. Another important cause of progressive peripheral field constriction is retinitis pigmentosa. 

8. Chronic Glaucoma In chronic glaucoma, progressive optic nerve damage produces characteristic visual-field abnormalities. Early defects may include: Paracentral scotomas. Nasal steps. Arcuate scotomas. As disease becomes advanced, the remaining visual field may become markedly constricted, producing: Tunnel vision. Therefore: Advanced chronic glaucoma → severe peripheral field constriction. 

9. Chronic Papilloedema Long-standing papilloedema from raised intracranial pressure can eventually damage optic nerve axons. Early papilloedema often causes an enlarged blind spot, while visual acuity may initially remain relatively preserved. If papilloedema persists: Chronic disc swelling → optic nerve damage → secondary optic atrophy → progressive visual-field loss. Advanced disease can therefore produce substantial field constriction and permanent visual impairment. 

10. Lesions Affecting Both Eyes When a lesion affects corresponding parts of the visual fields of both eyes, pathology at the optic chiasm or behind the chiasm should be considered. Important sites include: Optic chiasm. Optic tract. Lateral geniculate nucleus. Optic radiations. Occipital visual cortex. The exact field defect helps localise the lesion. 

11. Bitemporal Hemianopia Bitemporal hemianopia means loss of the temporal half of the visual field in both eyes. This pattern strongly suggests a lesion involving the optic chiasm. Therefore: Bitemporal hemianopia → think optic chiasm. 

12. Why Chiasmal Lesions Cause Bitemporal Hemianopia The nasal retinal fibres cross at the optic chiasm. These nasal retinal fibres carry information from the temporal visual fields. Compression of the central optic chiasm therefore preferentially damages the crossing nasal fibres. The result is: Loss of temporal visual field in both eyes → bitemporal hemianopia. 

13. Causes of Chiasmal Lesions Important causes include: Pituitary adenoma. Craniopharyngioma. Meningioma. Intracranial aneurysm, depending on its location. Other suprasellar masses may also compress the optic chiasm. 

14. Pituitary Adenoma A pituitary adenoma is a classic cause of bitemporal hemianopia. The pituitary gland lies beneath the optic chiasm. As a pituitary tumour expands upward from the sella turcica, it may compress the inferior aspect of the optic chiasm. Therefore: Pituitary mass → optic chiasm compression → bitemporal visual-field loss. Endocrine abnormalities may coexist depending on whether the tumour secretes hormones or interferes with normal pituitary function. 

15. Craniopharyngioma Craniopharyngiomas are tumours arising in the sellar or suprasellar region. Because of their proximity to the optic chiasm, they can cause: Visual-field defects. Reduced visual acuity. Endocrine abnormalities. Symptoms of raised intracranial pressure, particularly with larger lesions. Bitemporal hemianopia may occur from chiasmal compression. 

16. Homonymous Visual-Field Defects A homonymous visual-field defect affects the same side of the visual field in both eyes. For example: Right homonymous hemianopia → loss of the right visual field of both eyes. This indicates a lesion behind the optic chiasm on the opposite side. Therefore: Right homonymous field loss → left retrochiasmal lesion. Left homonymous field loss → right retrochiasmal lesion. 

17. Homonymous Quadrantanopia A homonymous quadrantanopia means loss of the same quarter of the visual field in both eyes. This commonly results from a lesion involving part of the optic radiations. The two important patterns are: Superior quadrantanopia → temporal lobe lesion. Inferior quadrantanopia → parietal lobe lesion. 

18. Superior Homonymous Quadrantanopia Fibres carrying information from the superior visual field travel through the inferior optic radiations, which loop anteriorly through the temporal lobe. This loop is known as Meyer’s loop. A temporal lobe lesion therefore produces a contralateral superior homonymous quadrantanopia. A useful memory phrase is: Temporal lesion → “pie in the sky.” For example: Left temporal lobe lesion → right superior homonymous quadrantanopia. 

19. Inferior Homonymous Quadrantanopia Fibres carrying the inferior visual field travel more superiorly through the parietal lobe. A parietal optic-radiation lesion therefore causes: Contralateral inferior homonymous quadrantanopia. A useful memory phrase is: Parietal lesion → “pie on the floor.” For example: Left parietal lesion → right inferior homonymous quadrantanopia. 

20. Homonymous Hemianopia Homonymous hemianopia means loss of the same half of the visual field in both eyes. It results from a retrochiasmal lesion. Possible sites include: Optic tract. Lateral geniculate nucleus. Optic radiations. Occipital cortex. 

21. Optic Tract Lesion An optic tract lesion produces a contralateral homonymous hemianopia. The defect is often relatively incongruous, meaning that the field defects in the two eyes are not exactly identical in shape or extent. For example: Left optic tract lesion → right homonymous hemianopia. 

22. Congruity and Lesion Location As lesions occur farther posteriorly along the visual pathway, homonymous field defects generally become more congruous. Congruous means that the field defects in the two eyes closely resemble each other. Therefore, as a general rule: Anterior retrochiasmal lesion → more incongruous. Posterior retrochiasmal lesion → more congruous. This is a useful localisation principle rather than an absolute rule. 

23. Lateral Geniculate Lesions The lateral geniculate nucleus/body is a relay station between the optic tract and optic radiations. Lesions here can cause a contralateral homonymous visual-field defect, sometimes with characteristic sectoral patterns depending on vascular anatomy. The original note associates a congruous homonymous hemianopia with a lateral geniculate lesion, but congruity alone does not precisely localise the lesion. 

24. Occipital Cortex Lesions The final part of the visual pathway is the primary visual cortex in the occipital lobe. An occipital cortex lesion typically causes a highly congruous contralateral homonymous hemianopia. One particularly important feature is: Macular sparing. 

25. Macular Sparing Macular sparing means that central vision is preserved despite loss of the surrounding homonymous visual field. This is classically associated with an occipital cortex lesion, particularly an occipital infarction. One explanation is that the occipital pole representing central vision may have overlapping vascular supply, although the mechanism is more complex than a simple fixed dual blood supply in every patient. Therefore: Homonymous hemianopia + macular sparing → strongly suggests occipital cortex involvement. 

26. Visual Field Defects – Note Form Complete monocular visual loss: severe ipsilateral retinal or optic nerve lesion; complete optic nerve transection is the classic anatomical example. 

Central scotoma: optic nerve or macular disease; optic neuritis is an important cause. 

Constricted visual field: chronic glaucoma, chronic papilloedema with optic nerve damage, or retinitis pigmentosa. 

Bitemporal hemianopia: optic chiasm lesion. 

Chiasmal causes: pituitary adenoma, craniopharyngioma, meningioma and other suprasellar masses; some aneurysms may also compress the chiasm. 

Superior homonymous quadrantanopia: contralateral temporal lobe/Meyer’s loop lesion. 

Inferior homonymous quadrantanopia: contralateral parietal optic-radiation lesion. 

Homonymous hemianopia: contralateral lesion behind the optic chiasm. 

Incongruous homonymous hemianopia: suggests a relatively anterior retrochiasmal lesion, such as the optic tract. 

Increasingly congruous field defects: generally suggest progressively more posterior lesions. 

Homonymous hemianopia with macular sparing: classically suggests an occipital cortex lesion. 

27. Easy Localisation Sequence Think of the visual pathway from front to back: One eye only → retina or optic nerve. 

Temporal fields of both eyes lost → optic chiasm. 

Same side of visual field lost in both eyes → opposite retrochiasmal pathway. 

Superior quadrant lost → opposite temporal lobe. 

Inferior quadrant lost → opposite parietal lobe. 

Very congruous homonymous hemianopia ± macular sparing → opposite occipital cortex. 

Key Clinical Pattern The most useful rule is: PRE-CHIASM → ONE EYE. CHIASM → BITEMPORAL HEMIANOPIA. POST-CHIASM → CONTRALATERAL HOMONYMOUS FIELD LOSS. For the optic radiations: Temporal lobe → superior quadrantanopia → “pie in the sky.” Parietal lobe → inferior quadrantanopia → “pie on the floor.” And finally: Occipital cortex → highly congruous homonymous hemianopia, often with macular sparing.

Medicine – Pupils, Pupillary Light Reflex, Miosis, Horner Syndrome and Mydriasis

The pupil regulates the amount of light entering the eye. Its size is controlled by opposing parasympathetic pupilloconstrictor fibres and sympathetic pupillodilator fibres.

Abnormal pupil size or reactivity can therefore help localise lesions involving the optic nerve, midbrain, oculomotor nerve, sympathetic pathway, iris, or autonomic nervous system.

An asterisk (*) signifies a common cause.

⸻

1. Parasympathetic Pupilloconstrictor Fibres

Parasympathetic fibres cause constriction of the pupil, or miosis.

The pathway begins in the Edinger–Westphal nucleus of the midbrain.

Preganglionic parasympathetic fibres then travel with the oculomotor nerve, CN III, to the ciliary ganglion in the orbit.

Postganglionic fibres travel through the short ciliary nerves to the:

Sphincter pupillae → constricts the pupil.

Ciliary muscle → allows accommodation for near vision.

Therefore:

Parasympathetic activation → miosis + accommodation.

⸻

2. Sympathetic Pupillodilator Fibres

Sympathetic fibres cause dilatation of the pupil, or mydriasis.

The pathway begins in the hypothalamus and descends through the brainstem to the ciliospinal centre of Budge, approximately at spinal cord levels C8–T2.

Preganglionic fibres then leave the spinal cord, pass through the sympathetic chain, and ascend to the superior cervical ganglion.

Postganglionic fibres accompany the internal carotid artery into the skull and ultimately reach the eye.

They supply the:

Dilator pupillae → pupil dilatation.

They also contribute to eyelid elevation through Müller’s superior tarsal muscle and supply sympathetic fibres involved in facial sweating.

⸻

3. Pupillary Light Reflex

The pupillary light reflex is the constriction of the pupils in response to light.

Shining light into one eye normally produces:

Direct response → constriction of the illuminated pupil.

Consensual response → constriction of the opposite pupil.

This occurs because the central pathway projects bilaterally to the Edinger–Westphal nuclei.

⸻

4. Afferent Limb of the Light Reflex

The afferent limb detects the incoming light stimulus.

The pathway is:

Retina → optic nerve (CN II) → optic chiasm/optic tract → pretectal nuclei of the midbrain.

An important correction to the original note is that the lateral geniculate body is not the principal relay of the pupillary light reflex.

The lateral geniculate nucleus is primarily part of the pathway responsible for conscious vision.

For the pupillary reflex, fibres leave the optic tract and synapse in the pretectal area of the midbrain.

⸻

5. Bilateral Midbrain Connection

Each pretectal nucleus sends fibres to both Edinger–Westphal nuclei.

This bilateral connection explains why shining light in one eye normally constricts both pupils.

Therefore:

One retina stimulated → both Edinger–Westphal nuclei activated → both pupils constrict.

⸻

6. Efferent Limb of the Light Reflex

The efferent limb is parasympathetic.

The pathway is:

Edinger–Westphal nucleus → CN III → ciliary ganglion → short ciliary nerves → sphincter pupillae → pupillary constriction.

Therefore:

Afferent limb = CN II.

Efferent limb = CN III parasympathetic fibres.

⸻

7. Pupillary Light Reflex – Note Form

Light enters eye → retina.

⸻

Retina → optic nerve, CN II.

⸻

Optic nerve fibres → optic chiasm and optic tract.

⸻

Fibres leave visual pathway → pretectal nuclei in midbrain.

⸻

Pretectal nuclei → bilateral Edinger–Westphal nuclei.

⸻

Edinger–Westphal nucleus → CN III.

⸻

CN III → ciliary ganglion.

⸻

Short ciliary nerves → sphincter pupillae.

⸻

Result → direct and consensual pupillary constriction.

⸻

8. Causes of a Small Pupil – Miosis

Miosis means abnormal or marked constriction of the pupil.

Important causes include:

Age-related or senile miosis.

Horner syndrome.

Argyll Robertson pupil.

Certain autonomic disorders.

Opiates.

Pilocarpine and other miotic drugs.

⸻

9. Senile Miosis

Pupils tend to become smaller with increasing age.

This physiological age-related reduction in pupil diameter is sometimes called senile miosis.

It is generally bilateral and does not itself indicate neurological disease.

⸻

10. Horner Syndrome

Horner syndrome results from interruption of the sympathetic pathway supplying the eye and face.

The classic features are:

Ptosis.

Miosis.

Anhidrosis, depending on the level of the lesion.

A traditional fourth feature is enophthalmos, although the eye is usually not truly displaced backward.

⸻

11. Miosis in Horner Syndrome

The sympathetic system normally activates the dilator pupillae muscle.

Loss of sympathetic input means the affected pupil cannot dilate normally.

Parasympathetic constrictor activity is therefore relatively unopposed.

The result is:

Ipsilateral miosis.

The difference in pupil size, or anisocoria, becomes more obvious in the dark because the abnormal pupil fails to dilate properly.

Therefore:

Horner anisocoria → greater in darkness.

⸻

12. Ptosis in Horner Syndrome

The sympathetic fibres supply Müller’s superior tarsal muscle, which contributes a small amount to upper-eyelid elevation.

Loss of this sympathetic supply causes a mild ptosis.

This differs from third nerve palsy, where paralysis of the levator palpebrae superioris may cause much more severe ptosis.

Therefore:

Horner → mild ptosis.

CN III palsy → often marked ptosis.

⸻

13. Anhidrosis

Anhidrosis means reduced or absent sweating.

Its distribution depends on where along the sympathetic pathway the lesion occurs.

Central or preganglionic lesions are more likely to cause significant facial anhidrosis.

Postganglionic lesions associated with the internal carotid artery may produce little or no facial anhidrosis because many sweat fibres have already travelled with the external carotid circulation.

⸻

14. Enophthalmos

Traditional descriptions of Horner syndrome include enophthalmos, meaning that the eye appears sunken.

In humans this is usually apparent rather than true enophthalmos.

The combination of mild upper-lid ptosis and slight elevation of the lower eyelid makes the palpebral opening smaller, giving the impression that the eye lies deeper in the orbit.

⸻

15. The Three-Neurone Sympathetic Pathway

The sympathetic pathway involved in Horner syndrome can be divided into:

First-order central neurone.

Second-order preganglionic neurone.

Third-order postganglionic neurone.

The site of interruption helps determine the possible underlying cause.

⸻

16. First-Order or Central Horner Syndrome

First-order fibres descend from the hypothalamus through the brainstem and cervical spinal cord.

Important causes include:

*Brainstem stroke or other vascular lesion. **

Tumour.

Demyelination, including multiple sclerosis.

Spinal cord lesions.

Other neurological findings are often present because central lesions usually involve neighbouring structures.

⸻

17. Vascular Causes*

A brainstem vascular lesion, particularly a lateral medullary stroke, can interrupt descending sympathetic fibres and cause Horner syndrome.

The patient may also have other brainstem signs, such as:

Vertigo.

Ataxia.

Dysphagia.

Sensory abnormalities.

Therefore, Horner syndrome accompanied by other acute neurological deficits should raise concern for a central vascular lesion.

⸻

18. Preganglionic Horner Syndrome

Second-order sympathetic fibres leave the spinal cord and travel through the upper chest and neck before reaching the superior cervical ganglion.

Because this pathway passes close to the lung apex, lesions in the chest can produce Horner syndrome.

⸻

19. Pancoast Tumour*

A Pancoast tumour, or superior sulcus lung tumour, is an important cause of preganglionic Horner syndrome.

The tumour occurs near the lung apex and may invade the sympathetic chain.

It may produce:

Horner syndrome.

Shoulder or arm pain.

Brachial plexus involvement.

Therefore:

Horner syndrome + shoulder/arm pain → consider an apical lung tumour.

⸻

20. Other Chest Causes

Other lesions affecting the sympathetic chain in the thoracic inlet or mediastinum can also cause Horner syndrome.

These include:

Mediastinal masses.

Other apical thoracic lesions.

A cervical rib was traditionally listed as a possible cause through local compression, although it is much less important clinically than malignant or traumatic causes.

⸻

21. Cervical Causes

The sympathetic chain passes through the neck, where it may be damaged by:

Cervical lymphadenopathy.

Neck trauma.

Thyroid or other cervical tumours.

Therefore, neck examination is important in unexplained Horner syndrome.

⸻

22. Surgical and Iatrogenic Causes*

Horner syndrome can occur following procedures involving the neck.

Examples include:

Thyroid surgery.

Carotid surgery, including carotid endarterectomy.

Other cervical or thoracic operations.

Modern arterial catheter procedures can also occasionally damage the sympathetic pathway, although older references to carotid angiography as a common cause reflect historical practice.

⸻

23. Postganglionic Horner Syndrome

Third-order sympathetic fibres leave the superior cervical ganglion and accompany the internal carotid artery toward the skull.

Important causes include:

Internal carotid artery dissection.

Cavernous sinus disease.

Other lesions along the internal carotid sympathetic plexus.

⸻

24. Internal Carotid Artery Dissection

Internal carotid artery dissection is an especially important cause of acute painful Horner syndrome.

The sympathetic fibres run along the wall of the internal carotid artery and may be damaged when the artery dissects.

A classic presentation is:

Acute unilateral Horner syndrome + ipsilateral neck, facial, or head pain.

This requires urgent assessment because carotid dissection can cause cerebral ischaemia and stroke.

⸻

25. Cavernous Sinus Lesion

Sympathetic fibres travel through the cavernous sinus alongside several cranial nerves.

A cavernous sinus lesion may therefore produce Horner syndrome together with:

Diplopia.

Ophthalmoplegia.

Trigeminal sensory abnormalities.

Other cranial nerve deficits.

⸻

26. Horner Syndrome – Note Form

Sympathetic lesion → Horner syndrome.

⸻

Miosis → loss of pupillary dilator activity.

⸻

Ptosis → loss of sympathetic supply to Müller muscle.

⸻

Anhidrosis → distribution depends on lesion level.

⸻

Apparent enophthalmos → narrowing of palpebral fissure rather than true posterior displacement.

⸻

Central causes: stroke, tumour, demyelination and spinal cord lesions.

⸻

Preganglionic causes: Pancoast tumour, thoracic/mediastinal lesions, neck tumour or trauma, thyroid or carotid surgery.

⸻

Postganglionic causes: internal carotid artery dissection and cavernous sinus lesions.

⸻

27. Argyll Robertson Pupil

The Argyll Robertson pupil is classically a small, irregular pupil that accommodates but does not react normally to light.

This phenomenon is called:

Light-near dissociation.

In simple terms:

No or poor light response.

Near/accommodation response preserved.

⸻

28. Association of Argyll Robertson Pupil

Argyll Robertson pupils are classically associated with neurosyphilis, particularly late syphilitic neurological disease.

The traditional memory phrase is:

“Accommodates but does not react.”

The finding is much less common in modern clinical practice than older textbooks suggest.

⸻

29. Myotonic Dystrophy

Pupillary abnormalities can occur in myotonic dystrophy, including relatively small pupils and impaired pupillary responses.

However, miosis is not usually the key diagnostic feature.

More characteristic findings include:

Myotonia.

Distal muscle weakness.

Facial and temporal muscle wasting.

Early cataracts.

Cardiac conduction disease.

⸻

30. Opiates

Opiates or opioids commonly cause bilateral marked pupillary constriction.

The classic description is:

Pinpoint pupils.

In opioid toxicity, this may occur with:

Reduced level of consciousness.

Respiratory depression.

Therefore:

Coma + respiratory depression + pinpoint pupils → strongly consider opioid toxicity, while remembering that other causes of coma can sometimes alter pupils as well.

⸻

31. Pilocarpine

Pilocarpine is a muscarinic cholinergic agonist.

It stimulates the sphincter pupillae and causes:

Miosis.

It has ophthalmic uses, although its role in modern glaucoma treatment is more limited than historically.

⸻

32. Causes of a Large Pupil – Mydriasis

Mydriasis means dilatation of the pupil.

It may result from:

Loss of parasympathetic constrictor activity.

or

Excess sympathetic activity/pharmacological stimulation.

Important causes include:

Adie tonic pupil.

Third nerve palsy.

Drugs.

Trauma.

Previous eye surgery.

⸻

33. Adie Tonic Pupil

An Adie tonic pupil usually results from damage to parasympathetic fibres in or after the ciliary ganglion.

It typically produces a pupil that is:

Dilated.

Poorly reactive to light.

Slow or tonic in its response to near stimulation and redilatation.

The near response is often better preserved than the light response, producing another form of light-near dissociation.

⸻

34. Holmes–Adie Syndrome

When the tonic pupil is associated with reduced or absent deep tendon reflexes, the condition is called Holmes–Adie syndrome.

Therefore:

Adie pupil + reduced tendon reflexes = Holmes–Adie syndrome.

It commonly affects otherwise healthy younger adults and is usually benign.

⸻

35. Third Nerve Palsy

The third cranial nerve carries parasympathetic fibres responsible for pupil constriction.

Damage to these fibres may therefore result in:

Dilated pupil.

Poor or absent light reaction.

If a large pupil occurs together with:

Ptosis.

Down-and-out eye.

Diplopia.

a third nerve palsy should be suspected.

⸻

36. Aneurysm and a Dilated Pupil

A particularly important emergency is:

Painful third nerve palsy + dilated pupil.

This raises concern for compression by a posterior communicating artery aneurysm.

Therefore, a new pupil-involving third nerve palsy requires urgent assessment.

⸻

37. Drugs Causing Mydriasis

Many drugs can cause pupillary dilatation.

Important examples include:

Atropine.

Tropicamide.

Sympathomimetic/stimulant drugs such as amphetamines.

Some antidepressants and other medications with anticholinergic effects.

Atropine and tropicamide cause mydriasis mainly by blocking parasympathetic muscarinic activity at the iris sphincter.

⸻

38. Tropicamide

Tropicamide is a short-acting antimuscarinic drug commonly used during ophthalmic examination to dilate the pupil.

It produces:

Mydriasis.

and some degree of:

Cycloplegia, or reduced accommodation.

⸻

39. Atropine

Atropine blocks muscarinic receptors.

In the eye it causes:

Mydriasis.

Cycloplegia.

Its ocular effects last considerably longer than those of tropicamide.

⸻

40. Trauma and Previous Eye Surgery

Direct trauma to the iris sphincter can leave the pupil abnormally dilated or irregular.

This is sometimes called traumatic mydriasis.

Previous ophthalmic surgery may also alter the shape, size or reactivity of the pupil.

Therefore, examination for:

Iris injury.

Surgical scars.

An irregular pupil.

may help identify a local ocular cause.

⸻

41. Small Pupil – Note Form

Senile miosis: physiological pupil narrowing with age.

⸻

Horner syndrome: miosis + mild ptosis ± anhidrosis.

⸻

Argyll Robertson pupil: small irregular pupil with light-near dissociation; classically neurosyphilis.

⸻

Opiates: bilateral pinpoint pupils, particularly important in opioid toxicity.

⸻

Pilocarpine: pharmacological muscarinic stimulation causing miosis.

⸻

42. Large Pupil – Note Form

Adie tonic pupil: large pupil with poor light response and tonic near response.

⸻

Holmes–Adie syndrome: Adie pupil + reduced/absent tendon reflexes.

⸻

Third nerve palsy: dilated pupil ± ptosis and down-and-out eye.

⸻

Atropine/tropicamide: antimuscarinic pupillary dilatation.

⸻

Amphetamines and other sympathomimetics: may cause mydriasis.

⸻

Trauma/surgery: damage to iris sphincter may cause a persistently large or irregular pupil.

⸻

43. Horner versus Third Nerve Palsy – Note Form

Horner syndrome → pupil SMALL.

Third nerve palsy → pupil may be LARGE.

⸻

Horner ptosis → mild.

Third nerve ptosis → often marked.

⸻

Horner eye movements → usually normal.

Third nerve palsy → eye movements markedly abnormal.

⸻

Horner eye position → no classic down-and-out deviation.

Third nerve palsy → down-and-out eye.

⸻

Horner anisocoria → greater in the DARK.

Parasympathetic pupil palsy → anisocoria usually greater in BRIGHT light because the large abnormal pupil cannot constrict.

⸻

Key Clinical Pattern

The easiest way to organise pupillary abnormalities is to ask which autonomic pathway has failed.

Parasympathetic fibres constrict the pupil.

Sympathetic fibres dilate the pupil.

Therefore:

Sympathetic failure → small pupil → Horner syndrome.

Parasympathetic failure → large pupil → third nerve palsy, Adie pupil or antimuscarinic drug effect.

For the light reflex remember:

CN II IN → midbrain → bilateral Edinger–Westphal nuclei → CN III OUT.

And the most important emergency patterns are:

Painful Horner syndrome → consider internal carotid artery dissection.

Painful third nerve palsy with a dilated pupil → urgently exclude posterior communicating artery aneurysm.

Medicine – Third Nerve Palsy

Third nerve palsy is dysfunction of the oculomotor nerve, cranial nerve III, which supplies most of the extraocular muscles, the levator palpebrae superioris, and parasympathetic fibres responsible for pupillary constriction.

A useful memory rule is:

LR6 SO4, all the rest 3

meaning:

Lateral rectus → CN VI

Superior oblique → CN IV

Most other extraocular muscles → CN III

1. Muscles Supplied by the Third Cranial Nerve

The oculomotor nerve supplies most muscles responsible for eye movement.

These include:

Medial rectus.

Superior rectus.

Inferior rectus.

Inferior oblique.

It also supplies:

Levator palpebrae superioris, which raises the upper eyelid.

The two major extraocular muscles not supplied by CN III are:

Superior oblique → CN IV.

Lateral rectus → CN VI.

2. Parasympathetic Fibres

The third cranial nerve also carries parasympathetic fibres to the eye.

These fibres ultimately supply the:

Sphincter pupillae → constricts the pupil.

Ciliary muscle → allows accommodation for near vision.

Therefore, a complete third nerve palsy may cause:

Dilated pupil.

Poor or absent pupillary reaction to light.

Loss of accommodation.

3. Location of the Third Nerve Nucleus

An important correction to the original note is that the oculomotor nucleus is located in the midbrain, not the pons.

It lies at approximately the level of the superior colliculus, close to the cerebral aqueduct.

Therefore:

CN III nucleus → midbrain.

CN VI nucleus → pons.

4. Main Features of Third Nerve Palsy

A complete third nerve palsy can produce a characteristic combination of:

Ptosis.

Dilated poorly reactive or unreactive pupil.

Impaired adduction.

Impaired elevation.

Impaired depression.

Eye resting in a “down and out” position.

These findings result from paralysis of most muscles supplied by CN III.

5. Ptosis

Ptosis occurs because the third nerve supplies the levator palpebrae superioris.

When this muscle is paralysed, the upper eyelid droops.

Therefore:

CN III palsy → levator weakness → ptosis.

In a complete palsy, the ptosis may be marked and may partially hide the abnormal position of the eye.

6. “Down and Out” Eye Position

In a complete third nerve palsy, most extraocular muscles are paralysed.

However, two muscles remain functional:

Lateral rectus → CN VI.

Superior oblique → CN IV.

The lateral rectus pulls the eye outward, while the superior oblique contributes to downward movement.

The result is the classic:

“Down and out” position of the affected eye.

7. Impaired Eye Movements

Because CN III supplies the medial, superior and inferior recti plus the inferior oblique, the affected eye has difficulty moving:

Medially.

Upward.

Downward.

Abduction is relatively preserved because the lateral rectus is supplied by CN VI.

8. Diplopia

Third nerve palsy usually causes diplopia because the two eyes are no longer aligned.

The exact direction in which diplopia is worst depends on the degree of weakness and which branches are affected.

In a complete palsy, the abnormal resting position is often obvious.

9. Pupillary Dilatation

The parasympathetic fibres responsible for pupillary constriction run superficially in the third nerve.

If these fibres are damaged, the pupil becomes:

Dilated.

Poorly reactive or unreactive to light.

A dilated pupil in the setting of a new third nerve palsy is particularly important because it may suggest a compressive lesion, especially an aneurysm.

10. Pupil-Involving Third Nerve Palsy

A painful third nerve palsy with a dilated pupil is a neurological emergency until a compressive aneurysm has been excluded.

The classic concern is a:

Posterior communicating artery aneurysm.

The aneurysm may compress the superficial parasympathetic fibres of CN III, producing early pupillary involvement.

Therefore:

Painful CN III palsy + dilated pupil → urgently exclude posterior communicating artery aneurysm.

11. Posterior Communicating Artery Aneurysm*

A posterior communicating artery aneurysm is one of the most important causes of third nerve palsy.

Typical findings may include:

Sudden severe headache.

Pain around the eye.

Ptosis.

Down-and-out eye.

Dilated poorly reactive pupil.

This presentation requires urgent vascular imaging and specialist assessment.

12. Microvascular Third Nerve Palsy*

Microvascular ischaemia is another common acquired cause, particularly in older adults with vascular risk factors.

Important associations include:

Diabetes mellitus.

Hypertension.

Other small-vessel disease.

Because the central motor fibres may be affected more than the superficial parasympathetic fibres, a microvascular palsy may be pupil-sparing.

13. Pupil-Sparing Third Nerve Palsy

A classic teaching pattern is:

Microvascular/diabetic CN III palsy → pupil often spared.

This is because the pupillary parasympathetic fibres lie superficially around the nerve and may escape central ischaemic damage.

However, pupil sparing is not absolute, and clinical assessment should not rely on this sign alone.

14. Demyelination

Demyelinating disease, including multiple sclerosis, can affect the oculomotor fascicles or associated brainstem pathways.

This is less common than microvascular or compressive causes but should be considered in younger patients or when other neurological symptoms are present.

15. Trauma

Head or orbital trauma may damage the third cranial nerve directly or indirectly.

Traumatic CN III palsy may be associated with:

Ptosis.

Ophthalmoplegia.

Pupillary abnormalities.

Other cranial nerve injuries.

The presence of multiple neurological deficits suggests more extensive injury.

16. Cavernous Sinus Disease

CN III passes through the lateral wall of the cavernous sinus.

Disease in this region can therefore affect the third nerve together with other cranial nerves.

Important neighbouring nerves include:

CN IV.

CN V1.

CN V2.

CN VI.

Therefore, a cavernous sinus lesion often causes multiple cranial neuropathies, not an isolated third nerve palsy.

17. Cavernous Sinus Thrombosis

Cavernous sinus thrombosis can cause:

Painful ophthalmoplegia.

Ptosis.

Proptosis.

Chemosis.

Sensory loss in V1/V2 distribution.

Fever or systemic infection signs, depending on cause.

It is an emergency requiring urgent treatment.

18. Orbital Tumour

An orbital tumour can impair ocular movements by:

Compressing cranial nerves.

Restricting extraocular muscles mechanically.

Causing proptosis.

Therefore, an orbital mass may produce ophthalmoplegia, but the pattern may not correspond neatly to a single cranial nerve palsy.

19. Thyroid Eye Disease

Thyroid eye disease can cause diplopia and restricted eye movement, but it is important to distinguish it from a true third nerve palsy.

In thyroid eye disease, the main problem is usually extraocular muscle enlargement and mechanical restriction, not direct CN III damage.

The inferior rectus and medial rectus are commonly affected.

Typical features may include:

Proptosis.

Lid retraction.

Restricted elevation.

Diplopia.

Exposure symptoms.

So thyroid eye disease is better considered a mimic of ocular motor nerve palsy rather than a classic cause of isolated CN III palsy.

20. Midbrain Lesions

Because the third nerve nucleus and fascicles are in the midbrain, lesions here may cause third nerve palsy together with other neurological abnormalities.

Possible causes include:

Stroke.

Tumour.

Demyelination.

Trauma.

Additional long-tract or cerebellar signs may help localise the lesion to the brainstem.

21. Third Nerve Palsy – Note Form

Cranial nerve: III, oculomotor nerve.

Nucleus: midbrain, not pons.

Muscles supplied: medial rectus, superior rectus, inferior rectus, inferior oblique and levator palpebrae superioris.

Muscles not supplied by CN III: lateral rectus and superior oblique.

Parasympathetic function: constricts pupil and assists accommodation.

Ptosis: caused by levator palpebrae weakness.

Eye position: down and out.

Eye movements impaired: upward, downward and medial movement.

Pupil: may be dilated and poorly reactive if parasympathetic fibres are involved.

*Microvascular causes: ** diabetes, hypertension and other vascular disease.

*Compressive cause: ** posterior communicating artery aneurysm.

Other causes: demyelination, trauma, cavernous sinus disease and midbrain lesions.

Orbital tumours: can cause ophthalmoplegia through compression or mechanical restriction.

Thyroid eye disease: usually a restrictive extraocular muscle disorder rather than a true isolated CN III palsy.

22. Important Clinical Example

If the patient has a right complete third nerve palsy:

Right eyelid is ptotic.

Right eye lies down and out.

Right eye cannot adduct normally.

Elevation and depression are impaired.

Right pupil may be dilated and unreactive if parasympathetic fibres are involved.

23. Pupil-Involving versus Pupil-Sparing – Note Form

Pupil-involving CN III palsy:

Think particularly about compressive pathology, especially a posterior communicating artery aneurysm.

Pupil-sparing CN III palsy:

Think particularly about microvascular ischaemia, such as diabetes.

However, this distinction is a useful clinical clue rather than an absolute rule.

24. Third, Fourth and Sixth Nerves – Quick Note Form

CN III: most extraocular muscles + levator + parasympathetic pupil fibres.

CN IV: superior oblique.

CN VI: lateral rectus.

CN III palsy: ptosis + down-and-out eye ± dilated pupil.

CN IV palsy: vertical diplopia worse looking down and in.

CN VI palsy: horizontal diplopia with impaired abduction.

Key Clinical Pattern

Remember third nerve palsy as:

CN III → most eye movements + eyelid elevation + pupil constriction.

Therefore:

Third nerve palsy → PTOSIS + DOWN-AND-OUT EYE + impaired adduction/elevation/depression ± DILATED PUPIL.

The most important emergency pattern is:

Painful third nerve palsy + dilated pupil → urgently exclude posterior communicating artery aneurysm.

And the important correction is:

The third nerve nucleus is in the MIDBRAIN, not the pons.

Medicine – Fourth Nerve Palsy

Fourth nerve palsy is dysfunction of the trochlear nerve, cranial nerve IV, which supplies the superior oblique muscle. Because the superior oblique is especially important for depressing the eye when it is adducted, trochlear nerve palsy classically causes vertical or oblique diplopia that is worse when looking down and in.

A useful memory rule is:

LR6 SO4, all the rest 3

meaning:

Lateral rectus → CN VI

Superior oblique → CN IV

Most other extraocular muscles → CN III

1. Function of the Fourth Cranial Nerve

The trochlear nerve supplies the superior oblique muscle.

The superior oblique has several actions, but clinically the most useful is:

Depression of the adducted eye.

It also contributes to:

Intorsion.

Abduction.

Therefore:

CN IV → superior oblique → especially helps the eye look down when turned inward.

2. Fourth Nerve Nucleus

The trochlear nucleus is located in the midbrain, approximately at the level of the inferior colliculus.

The fibres then cross before leaving the brainstem.

This means that the anatomy of a nuclear lesion is unusual compared with many other cranial nerves.

3. Dorsal Exit from the Brainstem

The trochlear nerve is unique because it is the only cranial nerve to emerge from the dorsal surface of the brainstem.

It exits from the posterior aspect of the midbrain and then wraps around the brainstem before passing forward.

This long and delicate intracranial course also makes it particularly vulnerable to trauma.

4. Trochlear Nerve Decussation

The fibres of the fourth nerve cross within the brainstem before emerging.

Therefore, a lesion of the trochlear nucleus affects the contralateral superior oblique muscle, whereas a lesion of the peripheral trochlear nerve affects the ipsilateral superior oblique.

For routine clinical examination, most isolated fourth nerve palsies are described according to the affected peripheral nerve and eye.

5. Effect of Fourth Nerve Palsy

When the superior oblique is weak, the affected eye cannot depress normally when it is adducted.

The patient therefore develops diplopia particularly during activities that require looking downward.

Typical examples include:

Reading.

Walking downstairs.

Looking down while eating.

Stepping off a kerb.

6. Diplopia

The diplopia is typically vertical or oblique, rather than purely horizontal.

It becomes most troublesome when looking:

Downward.

and

Toward the nose.

Therefore:

Fourth nerve palsy → diplopia worse on looking down and medially.

7. Why Looking Down and In Is Difficult

When the eye is adducted, the superior oblique is one of the main muscles responsible for depressing it.

If the superior oblique is paralysed:

Adducted eye + attempted downward gaze → impaired depression → vertical separation of the images.

This is why patients often notice symptoms when descending stairs or reading.

8. Head Tilt Compensation

Patients with fourth nerve palsy often adopt a compensatory head posture to reduce diplopia.

They may tilt their head away from the affected side.

This reduces the vertical misalignment caused by the weak superior oblique.

For example:

Right CN IV palsy → patient may tilt head to the left.

9. Bielschowsky Head-Tilt Test

The Bielschowsky head-tilt test can help identify a trochlear nerve palsy.

The vertical misalignment usually becomes worse when the head is tilted toward the affected side.

Therefore:

Right fourth nerve palsy → diplopia/hypertropia worsens with right head tilt.

This is an important clinical localisation sign.

10. Eye Position

The affected eye may appear slightly higher than the other eye, particularly in certain positions of gaze.

This is called hypertropia.

The misalignment is often most evident when the patient looks toward the opposite side and downward.

11. Vascular Causes*

Microvascular ischaemia is an important cause of acquired fourth nerve palsy, especially in older adults.

Important vascular risk factors include:

Diabetes mellitus.

Hypertension.

Other small-vessel vascular disease.

These palsies may occur suddenly and can sometimes improve spontaneously over weeks to months.

12. Diabetes Mellitus*

Diabetes can cause an ischaemic mononeuropathy affecting the trochlear nerve.

The patient may develop sudden vertical diplopia without major additional neurological deficits.

However, new cranial nerve palsy still needs assessment in the appropriate clinical context.

13. Trauma*

Head trauma is a particularly important cause of fourth nerve palsy.

The trochlear nerve is very thin and has a long intracranial course, making it vulnerable to shearing forces.

Trauma may cause:

Unilateral fourth nerve palsy.

or

Bilateral fourth nerve palsy.

Bilateral involvement should especially raise suspicion for significant head trauma.

14. Demyelination

Multiple sclerosis and other demyelinating diseases can affect the trochlear nucleus, fascicle, or nerve pathways.

This should be considered particularly in a younger patient with additional neurological symptoms.

15. Congenital Fourth Nerve Palsy

Fourth nerve palsy may be congenital.

Patients can compensate for many years by adopting a habitual head tilt.

The condition may only become obvious later when compensation fails or when the patient develops symptoms after illness, fatigue, or ageing.

16. Clues to Congenital Palsy

Features suggesting a longstanding congenital palsy may include:

Long-standing head tilt.

Facial asymmetry from chronic head posture.

Old photographs showing the same head tilt.

Large vertical fusion ability.

A patient may therefore first present in adulthood despite having had the condition since childhood.

17. Cavernous Sinus Syndrome

The trochlear nerve passes through the lateral wall of the cavernous sinus.

A cavernous sinus lesion can therefore affect CN IV along with several neighbouring cranial nerves.

These include:

CN III.

CN IV.

CN V1.

CN V2.

CN VI.

18. Cavernous Sinus Localisation

A cavernous sinus lesion may produce:

Diplopia.

Ophthalmoplegia.

Ptosis.

Reduced facial sensation in V1 or V2 distribution.

Because multiple nerves usually lie close together, an isolated fourth nerve palsy is less typical of a large cavernous sinus lesion than a combined cranial neuropathy.

19. Orbital Apex Syndrome

Disease at the orbital apex may affect several cranial nerves controlling eye movement.

These include:

CN III.

CN IV.

CN VI.

CN V1.

The optic nerve may also be involved.

Therefore, orbital apex disease may cause:

Ophthalmoplegia + visual loss + sensory abnormalities.

20. Fourth Nerve Palsy – Note Form

Cranial nerve: IV, trochlear nerve.

Muscle supplied: superior oblique.

Main clinical action: depresses the adducted eye.

Nucleus: midbrain.

Unique feature: only cranial nerve to emerge from the dorsal surface of the brainstem.

Another unique feature: fibres decussate before exiting.

Diplopia: vertical/oblique.

Diplopia worst: looking down and medially.

Common complaint: difficulty reading or walking downstairs.

Compensatory posture: head tilt away from affected side.

Bielschowsky test: vertical diplopia/misalignment worsens with head tilt toward affected side.

*Common acquired causes: ** vascular disease, diabetes and trauma.

Other causes: demyelination, congenital palsy, cavernous sinus syndrome and orbital apex syndrome.

21. Important Clinical Example

If the patient has a right fourth nerve palsy:

Right superior oblique is weak.

Right eye has difficulty looking down when adducted.

Vertical diplopia becomes worse when looking down and to the left.

Symptoms worsen with right head tilt.

The patient may compensate by tilting the head to the left.

22. Fourth versus Sixth Nerve Palsy – Quick Note Form

CN IV palsy: superior oblique weak.

CN VI palsy: lateral rectus weak.

CN IV diplopia: vertical/oblique.

CN VI diplopia: horizontal.

CN IV worst gaze: down and in.

CN VI worst gaze: toward affected side during abduction.

CN IV common functional complaint: difficulty descending stairs or reading.

CN VI common functional complaint: horizontal double vision, especially looking toward affected side.

Key Clinical Pattern

Remember fourth nerve palsy as:

CN IV → Superior Oblique → looks DOWN when eye is IN.

Therefore:

Fourth nerve palsy → vertical diplopia → worse looking down and medially → difficulty reading or descending stairs.

The important causes are:

Microvascular disease/diabetes + trauma + demyelination + congenital palsy + cavernous sinus disease + orbital apex disease.

And the classic anatomy points are:

Trochlear nucleus in midbrain + fibres cross + only cranial nerve to exit dorsally.

Medicine – Sixth Nerve Palsy

Sixth nerve palsy is dysfunction of the abducens nerve, cranial nerve VI, which supplies the lateral rectus muscle. Because the lateral rectus abducts the eye, sixth nerve palsy causes failure of abduction and produces horizontal diplopia, especially when looking toward the affected side.

A useful memory rule is:

LR6 SO4, all the rest 3

meaning:

Lateral rectus → CN VI

Superior oblique → CN IV

Most other extraocular muscles → CN III

1. Function of the Sixth Cranial Nerve

The abducens nerve supplies the lateral rectus muscle.

The lateral rectus moves the eye outward, away from the nose.

Therefore:

CN VI → lateral rectus → abduction of the eye.

2. Sixth Nerve Nucleus

The abducens nucleus is located in the pons, close to the floor of the fourth ventricle.

The fibres of the facial nerve loop around the abducens nucleus, forming the facial colliculus.

This anatomical relationship is important because pontine lesions may produce combined sixth and seventh cranial nerve abnormalities.

3. Effect of Sixth Nerve Palsy

When the lateral rectus is paralysed, the affected eye cannot abduct normally.

The unopposed action of the medial rectus, supplied by cranial nerve III, pulls the eye inward.

Therefore:

CN VI palsy → lateral rectus weakness → affected eye deviates medially.

This inward deviation is called esotropia.

4. Diplopia

Sixth nerve palsy typically causes horizontal diplopia.

The double vision becomes worse when the patient looks toward the affected side, because this requires contraction of the weak lateral rectus.

For example:

Right CN VI palsy → right eye cannot abduct → diplopia worse on looking right.

5. Diplopia at Distance

Diplopia may be particularly noticeable when looking at distant objects.

This is because distance fixation requires relatively greater divergence of the eyes.

Patients may turn their head toward the affected side to reduce diplopia.

6. Examination

Ask the patient to follow a target through the six cardinal positions of gaze.

In sixth nerve palsy, the affected eye shows:

Reduced or absent abduction.

The eye may be medially deviated in the primary position if the palsy is significant.

7. Raised Intracranial Pressure*

Raised intracranial pressure is an important cause of sixth nerve palsy.

The abducens nerve has a relatively long intracranial course and is vulnerable to stretching or displacement when intracranial pressure rises.

For this reason, sixth nerve palsy can occur even when the underlying pathology is not anatomically close to the sixth nerve nucleus.

8. False Localising Sign

A sixth nerve palsy caused by raised intracranial pressure is classically described as a false localising sign.

This means that the site of the cranial nerve palsy does not necessarily indicate the location of the underlying intracranial lesion.

For example, a distant mass lesion causing raised intracranial pressure may produce CN VI palsy through nerve stretching.

Therefore:

Raised ICP + CN VI palsy does not necessarily mean a pontine lesion.

9. Microvascular Causes*

Small-vessel ischaemia is a common cause of isolated sixth nerve palsy, particularly in older adults.

Important vascular risk factors include:

Diabetes mellitus.

Hypertension.

Other vascular disease.

These palsies are often termed microvascular cranial neuropathies.

10. Diabetes Mellitus

Diabetes can cause ischaemic injury to the sixth cranial nerve.

The patient may develop sudden-onset horizontal diplopia with an isolated abduction deficit.

Many presumed microvascular palsies improve spontaneously over weeks to months, but the diagnosis depends on the clinical context and exclusion of concerning alternative causes.

11. Demyelination

Multiple sclerosis and other demyelinating disorders can affect the sixth nerve nucleus, fascicle, or related brainstem pathways.

In a younger patient with sixth nerve palsy and additional neurological symptoms, demyelination should be considered.

12. Trauma*

Head trauma can injure the abducens nerve because of its long intracranial course and its passage over the petrous temporal bone.

Traumatic sixth nerve palsy may be unilateral or bilateral.

13. Cavernous Sinus Disease

The abducens nerve passes through the cavernous sinus, making it vulnerable to lesions in this region.

Causes may include:

Cavernous sinus thrombosis.

Tumours.

Aneurysmal or other vascular lesions.

Inflammatory disease.

14. Why Cavernous Sinus Lesions Are Important

Within the cavernous sinus, several cranial nerves lie close together.

These include:

CN III.

CN IV.

CN V1.

CN V2.

CN VI.

Therefore, a cavernous sinus lesion may produce a combination of:

Ophthalmoplegia.

Facial sensory loss.

Ptosis.

Diplopia.

An isolated sixth nerve palsy is possible, but multiple cranial nerve abnormalities make cavernous sinus disease more likely.

15. Orbital Apex Disease

Lesions at the orbital apex can affect several structures entering the orbit.

These may include:

CN II.

CN III.

CN IV.

CN VI.

Branches of CN V1.

Orbital apex disease may therefore produce ophthalmoplegia together with visual loss or sensory abnormalities.

16. Pontine Lesions

A lesion involving the abducens nucleus or fascicle within the pons can cause sixth nerve dysfunction.

Because of nearby structures, there may be additional neurological findings such as:

Facial weakness.

Gaze abnormalities.

Long-tract motor or sensory signs.

A nuclear lesion may produce more complex horizontal gaze abnormalities than an isolated peripheral sixth nerve palsy.

17. Sixth Nerve Palsy – Note Form

Cranial nerve: VI, abducens nerve.

Muscle supplied: lateral rectus.

Action: abducts the eye.

Nucleus: pons.

Palsy: affected eye fails to abduct.

Eye position: deviates medially because medial rectus is unopposed.

Diplopia: horizontal.

Diplopia worst: looking toward the affected side.

*Raised intracranial pressure: ** important cause and classic false localising sign.

*Microvascular causes: ** diabetes, hypertension and other vascular disease.

Other causes: demyelination, trauma, cavernous sinus disease and orbital apex disease.

18. Important Clinical Example

If the patient has a right sixth nerve palsy:

Right lateral rectus is weak.

Right eye cannot move fully to the right.

Right eye tends to deviate medially.

Horizontal diplopia becomes worse when looking to the right.

19. Localisation Clues

Isolated CN VI palsy in an older diabetic patient → consider microvascular ischaemia.

CN VI palsy + headache/papilloedema → consider raised intracranial pressure.

CN VI + III/IV/V abnormalities → consider cavernous sinus lesion.

CN VI + visual loss/multiple orbital nerve deficits → consider orbital apex disease.

CN VI + other brainstem signs → consider pontine lesion or demyelination.

Key Clinical Pattern

Remember sixth nerve palsy as:

CN VI → lateral rectus → abduction.

Therefore:

Sixth nerve palsy → eye cannot abduct → eye turns inward → horizontal diplopia worse on looking toward the affected side.

The most important causes to remember are:

Raised intracranial pressure + microvascular disease/diabetes + demyelination + trauma + cavernous sinus disease + orbital apex disease.

And the classic exam phrase is:

Raised ICP causing sixth nerve palsy = false localising sign.

Medicine – Facial Nerve (Cranial Nerve VII)

The facial nerve, cranial nerve VII, is a mixed cranial nerve with motor, sensory, special sensory, and parasympathetic functions. A useful way to remember its major functions is:

Face + Ear + Taste + Tears + Saliva.

Its most obvious function is controlling the muscles of facial expression, but it also supplies the stapedius muscle, carries taste from the anterior two-thirds of the tongue, and provides parasympathetic fibres to the lacrimal and salivary glands.

1. Motor Supply to the Face

The facial nerve provides motor innervation to the muscles of facial expression.

These muscles allow a person to:

Raise the eyebrows.

Close the eyes tightly.

Smile.

Show the teeth.

Puff out the cheeks.

Frown.

Weakness of these movements is therefore an important sign of facial nerve dysfunction.

2. Upper versus Lower Facial Muscles

The cortical control of the facial nucleus is clinically important.

The part of the facial nucleus controlling the upper face receives corticobulbar input from both cerebral hemispheres.

The part controlling the lower face receives predominantly contralateral cortical input.

This explains the major difference between upper motor neurone and lower motor neurone facial palsy.

3. Motor Supply to Stapedius

The facial nerve supplies the stapedius muscle in the middle ear.

Stapedius normally reduces excessive movement of the stapes in response to loud sounds.

Facial nerve damage proximal to the stapedius branch can therefore cause hyperacusis, meaning that ordinary sounds are perceived as abnormally loud or uncomfortable.

Therefore:

CN VII lesion → stapedius paralysis → hyperacusis.

4. Sensory Supply to the Ear

The facial nerve carries a small amount of general somatic sensation from part of the external auditory canal and external ear.

This sensory territory is small because most sensation around the ear is supplied by other nerves.

Nevertheless, the association of CN VII with the external auditory canal becomes particularly relevant in Ramsay Hunt syndrome.

5. Taste

Taste fibres from the anterior two-thirds of the tongue travel through the chorda tympani, a branch associated with the facial nerve.

Therefore, a facial nerve lesion proximal to the origin of the chorda tympani can produce:

Reduced or absent taste from the anterior two-thirds of the tongue on the affected side.

6. Chorda Tympani

The chorda tympani has two particularly important functions.

It carries:

Taste fibres from the anterior two-thirds of the tongue.

and

Parasympathetic secretomotor fibres to the submandibular and sublingual salivary glands.

Therefore, CN VII is involved not only in taste but also in salivation.

7. Lacrimal Gland

Parasympathetic fibres associated with the facial nerve supply the lacrimal gland through the greater petrosal nerve and associated pathways.

These fibres stimulate tear production.

A sufficiently proximal facial nerve lesion can therefore impair lacrimation and contribute to dryness of the eye.

8. Salivary Glands

The facial nerve also provides parasympathetic secretomotor fibres to:

Submandibular gland.

Sublingual gland.

The parotid gland is not supplied parasympathetically by the facial nerve.

Its secretomotor parasympathetic supply comes from the glossopharyngeal nerve, CN IX.

This distinction is clinically important because the facial nerve passes through the parotid gland but does not provide its secretomotor innervation.

9. Facial Nerve Branches

After leaving the stylomastoid foramen, the facial nerve enters the parotid gland and divides into five major terminal motor branches.

These are:

Temporal.

Zygomatic.

Buccal.

Marginal mandibular.

Cervical.

10. Correction to the Original Branch List

The original list gives:

Temporal, ophthalmic, maxillary, mandibular and cervical.

This mixes the branches of the facial nerve with divisions of the trigeminal nerve, CN V.

The correct five terminal branches of CN VII are:

Temporal → Zygomatic → Buccal → Marginal mandibular → Cervical.

11. Easy Memory for the Five Branches

A traditional mnemonic is:

To Zanzibar By Motor Car

T → Temporal

Z → Zygomatic

B → Buccal

M → Marginal mandibular

C → Cervical

These are motor branches supplying the muscles of facial expression.

12. Trigeminal Nerve Branches – Important Distinction

The terms ophthalmic, maxillary and mandibular belong primarily to the trigeminal nerve, cranial nerve V.

They are:

V1 → Ophthalmic.

V2 → Maxillary.

V3 → Mandibular.

Therefore:

CN V → Ophthalmic, Maxillary, Mandibular.

CN VII → Temporal, Zygomatic, Buccal, Marginal mandibular, Cervical.

13. Facial Nerve Palsy

Facial weakness can result from either an:

Upper motor neurone lesion.

or

Lower motor neurone lesion.

The pattern of facial weakness helps localise the lesion.

14. Upper Motor Neurone Facial Palsy

An UMN facial palsy results from damage to corticobulbar pathways above the facial nucleus.

Because the upper facial muscles receive bilateral cortical innervation, they are relatively preserved in a unilateral UMN lesion.

Therefore, an UMN lesion classically causes:

Contralateral lower facial weakness with relative forehead sparing.

15. Forehead Sparing

Suppose a patient has a left cerebral stroke affecting corticobulbar fibres.

The patient may develop:

Right lower facial weakness.

However, the patient may still be able to wrinkle the forehead and close the eyes relatively well because the upper facial nucleus receives bilateral cortical input.

Therefore:

Forehead sparing → think UMN lesion.

16. Causes of UMN Facial Weakness

Important causes include:

Stroke.

Multiple sclerosis.

Intracranial tumour or other central structural lesions.

These lesions affect the corticobulbar pathways rather than the peripheral facial nerve itself.

17. Stroke

Stroke is an important cause of acute UMN facial weakness.

The typical pattern is:

Contralateral lower facial weakness + forehead relatively spared.

Other neurological deficits may occur simultaneously, such as:

Arm or leg weakness.

Dysarthria.

Sensory abnormalities.

Aphasia, depending on the site of the stroke.

18. Multiple Sclerosis

Multiple sclerosis can produce facial weakness when demyelinating lesions involve central corticobulbar pathways or the facial nerve pathway within the brainstem.

The exact clinical pattern therefore depends on the location of the demyelinating plaque.

Other neurological manifestations of MS may coexist.

19. Lower Motor Neurone Facial Palsy

An LMN facial palsy occurs when the facial nucleus in the pons or the facial nerve itself is affected.

The lesion causes weakness of the entire ipsilateral half of the face.

Therefore, the patient may be unable to:

Wrinkle the forehead.

Close the eye tightly.

Smile normally.

Puff out the cheek.

20. LMN Facial Palsy and the Forehead

Unlike an UMN lesion, an LMN lesion does not spare the forehead.

Therefore:

Whole ipsilateral face weak → LMN facial palsy.

Contralateral lower face weak with forehead spared → UMN facial palsy.

This is one of the most useful bedside distinctions.

21. Bell Palsy

Bell palsy is an acute idiopathic peripheral facial nerve palsy and is one of the most common causes of an isolated LMN facial palsy.

It usually develops rapidly, often over hours.

The patient develops unilateral weakness involving both the upper and lower face.

22. Features of Bell Palsy

Patients may have:

Unilateral facial weakness.

Inability to close the affected eye completely.

Drooping of the corner of the mouth.

Difficulty drinking because fluid escapes from the mouth.

Reduced taste, depending on lesion location.

Hyperacusis, depending on involvement of the stapedius branch.

Some patients experience discomfort around the ear.

23. Eye Protection in Bell Palsy

Inability to close the eyelid can expose the cornea.

This may lead to:

Corneal dryness.

Exposure keratitis.

Corneal ulceration in severe cases.

Therefore, eye protection and lubrication are important when eye closure is impaired.

24. Ramsay Hunt Syndrome

Ramsay Hunt syndrome is caused by reactivation of varicella-zoster virus involving the facial nerve, usually around the geniculate ganglion.

It can produce a severe LMN facial palsy.

25. Features of Ramsay Hunt Syndrome

The classic pattern includes:

Ipsilateral LMN facial weakness.

Severe ear pain.

Vesicular eruption in or around the external auditory canal or pinna.

Vestibulocochlear involvement may also produce:

Hearing loss.

Tinnitus.

Vertigo.

Therefore:

Facial palsy + painful ear vesicles → Ramsay Hunt syndrome.

26. Acoustic Neuroma

The older term acoustic neuroma generally refers to a vestibular schwannoma.

This is a benign tumour usually arising from the vestibular component of CN VIII.

As the tumour enlarges, it may compress nearby cranial nerves, including CN VII.

The more typical early presentation is:

Progressive unilateral sensorineural hearing loss.

Unilateral tinnitus.

Imbalance.

Facial weakness tends to occur with larger lesions rather than being the usual initial manifestation.

27. Parotid Tumours

The facial nerve passes through the parotid gland, where it divides into its terminal branches.

A parotid tumour can therefore compress or invade the facial nerve and produce an LMN facial palsy.

Facial weakness associated with a parotid mass is particularly concerning for malignant involvement and requires investigation.

28. Guillain–Barré Syndrome

Guillain–Barré syndrome can involve the facial nerves.

Facial weakness is frequently bilateral, although it may initially be asymmetric.

Other features may include:

Ascending limb weakness.

Areflexia.

Sensory symptoms.

Autonomic dysfunction.

Respiratory weakness.

Therefore:

Bilateral LMN facial weakness + areflexic ascending weakness → consider GBS.

29. Examination of the Facial Nerve

To examine the motor component of CN VII, ask the patient to:

Raise the eyebrows.

Wrinkle the forehead.

Close the eyes tightly.

Show the teeth.

Smile.

Puff out the cheeks.

These movements allow assessment of different facial muscle groups and help determine whether weakness involves the upper face, lower face, or both.

30. UMN versus LMN Facial Palsy – Note Form

UMN lesion: corticobulbar pathway above facial nucleus.

LMN lesion: facial nucleus or facial nerve.

UMN weakness: mainly contralateral lower face.

LMN weakness: entire ipsilateral half of face.

UMN forehead: relatively spared.

LMN forehead: weak.

UMN eye closure: relatively preserved.

LMN eye closure: impaired.

UMN causes: stroke, MS, intracranial tumour.

LMN causes: Bell palsy, Ramsay Hunt syndrome, vestibular schwannoma, parotid tumour and GBS.

31. Facial Nerve – Note Form

Cranial nerve: VII.

Motor: muscles of facial expression.

Ear: supplies stapedius.

Stapedius paralysis: may cause hyperacusis.

General sensation: small area of external auditory canal/external ear.

Taste: anterior two-thirds of tongue via chorda tympani.

Tears: parasympathetic supply to lacrimal gland.

Saliva: parasympathetic supply to submandibular and sublingual glands.

Five terminal branches: temporal, zygomatic, buccal, marginal mandibular and cervical.

Bell palsy: acute LMN facial palsy affecting the whole ipsilateral face.

Ramsay Hunt: facial palsy + painful vesicles around/in the ear ± hearing or vestibular symptoms.

Stroke: usually contralateral lower facial weakness with forehead sparing.

GBS: may produce bilateral LMN facial weakness.

Key Clinical Pattern

Remember the main functions of CN VII as:

FACE + EAR + TASTE + TEARS + SALIVA.

The five terminal branches are:

Temporal → Zygomatic → Buccal → Marginal mandibular → Cervical.

The most important localisation rule is:

UMN lesion → contralateral LOWER face weak + forehead spared.

LMN lesion → ipsilateral WHOLE face weak + forehead involved.

And remember:

Bell palsy → isolated LMN facial palsy.

Ramsay Hunt → LMN facial palsy + painful ear vesicles.

Stroke → UMN facial weakness with forehead sparing.